EP3677572B1 - Production method for pyrazole-4-carboxamide derivative - Google Patents

Production method for pyrazole-4-carboxamide derivative Download PDF

Info

Publication number
EP3677572B1
EP3677572B1 EP18850343.7A EP18850343A EP3677572B1 EP 3677572 B1 EP3677572 B1 EP 3677572B1 EP 18850343 A EP18850343 A EP 18850343A EP 3677572 B1 EP3677572 B1 EP 3677572B1
Authority
EP
European Patent Office
Prior art keywords
group
haloalkyl
hydrogen atom
pyrazole
atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP18850343.7A
Other languages
German (de)
French (fr)
Other versions
EP3677572A4 (en
EP3677572C0 (en
EP3677572A1 (en
Inventor
Yusuke Kurihara
Koki Sato
Ayase WASUZU
Yu Yamada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Finichem Co Ltd
Original Assignee
Japan Finichem Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Finichem Co Ltd filed Critical Japan Finichem Co Ltd
Publication of EP3677572A1 publication Critical patent/EP3677572A1/en
Publication of EP3677572A4 publication Critical patent/EP3677572A4/en
Application granted granted Critical
Publication of EP3677572C0 publication Critical patent/EP3677572C0/en
Publication of EP3677572B1 publication Critical patent/EP3677572B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Definitions

  • the present invention relates to a method of producing a pyrazole-4-carboxamide derivative.
  • Pyrazole-4-carboxamide derivatives are useful as agricultural chemicals or intermediates thereof, and so on.
  • PTL 1 WO 2013/186325 A
  • PTL 2 WO 2003/070705 A
  • PTL 3 WO 2006/087343 A
  • fluxapyroxad
  • PTL 4 WO 2007/115765 A
  • PTL 5 WO 2007/048556 A
  • PTL 6 EP 0737682 A
  • penthiopyrad have excellent effects as an agricultural fungicide and are widely used in the world for controlling crop diseases.
  • the acid chloride is prepared by using a chlorinating agent, such as thionyl chloride and oxalyl chloride, and there were involved such problems that the number of steps to reach the carboxamide is long, that a reagent which is dangerous in handling for preparation of the acid chloride must be used, and that large quantities of waste acid and waste water come out after the reaction.
  • a chlorinating agent such as thionyl chloride and oxalyl chloride
  • Examples of the background art of the production method of a pyrazole-4-carboxamide derivative using the aminolysis reaction in the presence of a base include the following patent literatures: PTL 10 ( WO 2012/055864 A ) and PTL 11 ( WO 2012/175511 A ).
  • PTL 10 ( WO 2012/055864 A ) describes that the pyrazole-4-carboxamide derivative can be produced from a pyrazole-4-carboxylic acid ester and an amine by using a bulky non-nucleophilic base, such as potassium tert-butoxide.
  • a bulky non-nucleophilic base such as potassium tert-butoxide.
  • the base is limited to the non-nucleophilic base, and silica gel chromatography is needed for purification of the target material, and therefore, it is hard to say that the foregoing method is an industrial production method.
  • PTL 11 ( WO 2012/175511 A ) describes that the pyrazole-4-carboxamide derivative can be produced from a pyrazole-4-carboxylic acid ester and an amine by using a metal alkoxide as the base.
  • a step of reducing the pressure in the system and removing the by-produced alcohol through azeotropic distillation with toluene as a solvent is needed, and from the standpoint of complicated operation and increase of waste liquids, it is hard to say that the method is advantageous as an industrial production method.
  • the present invention is one solving the aforementioned problems involved in the background art and is to provide an industrial production method in which a pyrazole-4-carboxamide derivative that is useful as an agricultural fungicide can be obtained simply and in high yield and high purity as compared with the conventional method.
  • the present inventors made extensive and intensive investigations regarding a method of producing a pyrazole-4-carboxamide derivative of the formula (1) through an aminolysis reaction of a pyrazole carboxylic acid ester of the formula (2) and an amine of the formula (3) in a solvent in the presence of a base according to the following reaction formula (A).
  • reaction formula (A) it has been found that the reaction can be completed without removing a by-produced alcohol or phenyl, which is needed to be removed outside the system in the general aminolysis reaction, outside the system, thereby leading to accomplishment of the present invention.
  • the present invention is to provide an industrial production method in which not only the pyrazole-4-carboxamide derivative represented by the formula (1) is obtained by a simple operation and in high yield and high purity, but also it is possible to reduce the quantities of waste acid and waste water.
  • R, R 1 , R 2 , R 3 , and Qx in the formulae (1), (2), and (3) are respectively described later.
  • a pyrazole-4-carboxamide derivative according to the present invention it is possible to obtain the pyrazole-4-carboxamide derivative which is useful as an agricultural fungicide, simply and in high yield and high purity as compared with the conventional method by a short process and a simple operation, and the production method of the present invention can be adopted as an industrial production method.
  • the present invention relates to a production method of a pyrazole-4-carboxamide derivative represented by the formula (1) through an aminolysis reaction of a pyrazole-4-carboxylic acid ester of the formula (2) and an amine of the formula (3) in a solvent in the presence of a base according to the reaction formula (A) and is an invention of the production method in which on the occasion of reaction, the reaction can be completed without removing a by-produced alcohol or phenol outside the reaction system.
  • the pyrazole-4-carboxamide derivative obtained by the aforementioned reaction is a compound represented by the formula (1).
  • the pyrazole-4-carboxamide derivative represented by the formula (1) includes not only a single optical isomer and a diastereoisomer but also morphologies of a racemic mixture, a diastereoisomer mixture, and a partially separated mixture of such a compound, caused by the structure of the amine represented by the formula (2).
  • the racemic mixture and the diastereoisomer mixture each mean a mixture of isomers thereof (racemate and diastereomer); and the partially separated mixture means a mixture remained resulting from separation of a part of isomers from isomers constituting a racemic mixture and a diastereoisomer mixture (for example, in the case of a racemate, a mixture of isomers in which as a result of separation of a part of the R-form or the S-form, a ratio of the R-form and S-form has changed from a typical value of 1/1 to a value of not 1/1).
  • the compound represented by the formula (1) is one mentioned below.
  • R 1 is a hydrogen atom, a C1-C4 alkyl group, a C1-C4 haloalkyl group, a C3-C6 cycloalkyl group, a C3-C6 halocycloalkyl group, a C1-C4 alkoxy group, a C1-C4 haloalkoxy group, a C1-C4 alkylthio group, a C1-C4 haloalkylthio group, an aralkyl group, or an aryl group, preferably a C1-C4 alkyl group, and especially preferably a methyl group.
  • R 2 is a hydrogen atom, a halogen atom, a C1-C4 alkyl group, a C1-C4 haloalkyl group, a C3-C6 cycloalkyl group, a C3-C6 halocycloalkyl group, a C1-C4 alkoxy group, a C1-C4 haloalkoxy group, a C1-C4 alkylthio group, a C1-C4 haloalkylthio group, an aralkyl group, or an aryl group, preferably a C1-C4 haloalkyl group, and especially preferably a difluoromethyl group or a trifluoromethyl group.
  • R 3 is a hydrogen atom, a halogen atom, a C1-C4 alkyl group, a C1-C4 haloalkyl group, a C3-C6 cycloalkyl group, a C3-C6 halocycloalkyl group, a C1-C4 alkoxy group, a C1-C4 haloalkoxy group, a C1-C4 alkylthio group, a C1-C4 haloalkylthio group, an aralkyl group, or an aryl group, and especially preferably a hydrogen atom.
  • the pyrazole-4-carboxylic acid ester represented by the formula (2), which is one of the starting substances, is one mentioned below.
  • R 1 is a hydrogen atom, a C1-C4 alkyl group, a C1-C4 haloalkyl group, a C3-C6 cycloalkyl group, a C3-C6 halocycloalkyl group, a C1-C4 alkoxy group, a C1-C4 haloalkoxy group, a C1-C4 alkylthio group, a C1-C4 haloalkylthio group, an aralkyl group, or an aryl group, preferably a C1-C4 alkyl group, and especially preferably a methyl group.
  • R 2 is a hydrogen atom, a halogen atom, a C1-C4 alkyl group, a C1-C4 haloalkyl group, a C3-C6 cycloalkyl group, a C3-C6 halocycloalkyl group, a C1-C4 alkoxy group, a C1-C4 haloalkoxy group, a C1-C4 alkylthio group, a C1-C4 haloalkylthio group, an aralkyl group, or an aryl group, preferably a C1-C4 haloalkyl group, and especially preferably a difluoromethyl group or a trifluoromethyl group.
  • R 3 is a hydrogen atom, a halogen atom, a C1-C4 alkyl group, a C1-C4 haloalkyl group, a C3-C6 cycloalkyl group, a C3-C6 halocycloalkyl group, a C1-C4 alkoxy group, a C1-C4 haloalkoxy group, a C1-C4 alkylthio group, a C1-C4 haloalkylthio group, an aralkyl group, or an aryl group, and especially preferably a hydrogen atom.
  • R is a C1-C4 alkyl group or an optionally substituted phenyl group, preferably a C1-C4 alkyl group, and especially preferably an ethyl group.
  • Qx represents any substituent (amine residue) of Q1, Q2, Q3, Q4, Q5, and Q6.
  • R 4 , R 5 , and R 6 are the same as or different from each other and are each a C1-C4 alkyl group, a C1-C4 haloalkyl group, a C3-C6 cycloalkyl group, or a C3-C6 halocycloalkyl group, provided that R 5 and R 6 may be bonded to each other to form a C3-C6 cycloalkyl group; and preferably a C1-C4 alkyl group.
  • R 4 , R 5 , and R 6 are each a methyl group.
  • V represents CH(R 7 ), N(R 8 ), an oxygen atom, or a sulfur atom; and R 7 and R 8 are each a hydrogen atom, a C1-C4 alkyl group, a C1-C4 haloalkyl group, a C3-C6 cycloalkyl group, or a C3-C6 halocycloalkyl group.
  • R 7 is a hydrogen atom.
  • Y represents a halogen atom, a C1-C4 alkyl group, a C1-C4 haloalkyl group, a C1-C4 alkoxy group, a C1-C4 haloalkoxy group, an SH group, a C1-C4 alkylthio group, or a C1-C4 haloalkylthio group, preferably a halogen atom, and especially preferably a fluorine atom.
  • n is an integer of 0 to 3, preferably 0 or 1, and especially preferably 1.
  • the substitution position of the fluorine atom is especially preferably the 7-position of the indane-amine.
  • Y 1 represents a hydrogen atom, a halogen atom, a C1-C6 alkyl group, a C1-C6 haloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, an SH group, a C1-C6 alkylthio group, or a C1-C6 haloalkylthio group, and preferably a hydrogen atom, a C1-C6 alkyl group, or a halogen atom.
  • n represents an integer of 1 to 5, and when n is 2, 3, 4, or 5, then Y 1 's may be the same as or different from each other.
  • Y 1 and Z each represent a hydrogen atom, a halogen atom, a C1-C6 alkyl group, a C1-C6 haloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, an SH group, a C1-C6 alkylthio group, or a C1-C6 haloalkylthio group, and preferably a hydrogen atom or a halogen atom.
  • p represents an integer of 1 to 4, and when p is 2, 3, or 4, then Y 1 's may be the same as or different from each other.
  • n an integer of 1 to 5, and when n is 2, 3, 4, or 5, then Z's may be the same as or different from each other.
  • R 9 , R 10 , R 11 , R 12 , R 13 , and R 14 are the same as or different from each other and each represent a hydrogen atom, a halogen atom, a C1-C6 alkyl group, a C1-C6 haloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, an SH group, a C1-C6 alkylthio group, or a C1-C6 haloalkylthio group, and preferably a hydrogen atom or a C1-C6 alkyl group.
  • R 11 and R 12 may be bonded to each other to form a C3-C6 cycloalkyl group and R 13 and R 14 may be bonded to each other to form a C3-C6 cycloalkyl group.
  • W represents a methylene group, a methine group substituted with a C1-C6 haloalkyl group, or a terminal end-substituted vinyl group represented by the formula (4).
  • T represents a C1-C6 haloalkyl group or a halogen atom, and preferably a chlorine atom.
  • Y 1 represents a hydrogen atom, a halogen atom, a C1-C6 alkyl group, a C1-C6 haloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, an SH group, a C1-C6 alkylthio group, or a C1-C6 haloalkylthio group, and preferably a C1-C6 alkyl group.
  • n represents an integer of 1 to 3, and when m is 2 or 3, then Y 1 's may be the same as or different from each other.
  • G represents an oxygen atom, a sulfur atom, or N(R 15 ), and R 15 represents a hydrogen atom or a C1-C6 alkyl group, and G is preferably a sulfur atom.
  • Y 1 represents a hydrogen atom, a halogen atom, a C1-C6 alkyl group, a C1-C6 haloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, an SH group, a C1-C6 alkylthio group, or a C1-C6 haloalkylthio group, and preferably a C1-C6 alkyl group.
  • n represents an integer of 1 to 3, and when m is 2 or 3, then Y 1 's may be the same as or different from each other.
  • G represents an oxygen atom, a sulfur atom, or N(R 15 ), and R 15 represents a hydrogen atom or a C1-C6 alkyl group, and G is preferably a sulfur atom.
  • Examples of the pyrazole-4-carboxamide derivative represented by the formula (1) include:
  • Examples of the pyrazole-4-carboxylic acid ester represented by the formula (2) and the amine represented by the formula (3), all of which are used for the production, include compounds having a substituent corresponding to the pyrazole-4-carboxamide derivative represented by the formula (1), respectively.
  • the production method of the pyrazole-4-carboxamide derivative of the present invention is a method of producing the pyrazole-4-carboxamide derivative represented by the formula (1) through an aminolysis reaction of the pyrazole-4-carboxylic acid ester represented by the formula (2) and the amine represented by the formula (3) in a solvent in the presence of a base and is characterized such that the reaction is completed without removing the by-produced alcohol or phenol outside the system.
  • the amount of the pyrazole-4-carboxylic acid ester is in a range of 1.0 to 2.0 equivalents, and preferably in a range of 1.0 to 1.5 equivalents to 1.0 equivalent of the amine.
  • the base to be used is preferably a metal alkoxide, and more preferably a non-bulky metal alkoxide.
  • examples thereof include lithium methoxide, lithium ethoxide, sodium methoxide, sodium ethoxide, potassium methoxide, and potassium ethoxide, with sodium methoxide and sodium ethoxide being especially preferred.
  • the use amount of the base is preferably in a range of 1.0 to 7.0 equivalents, more preferably in a range of 1.0 to 5.0 equivalents, still more preferably in a range of 1.0 to 3.0 equivalents, especially preferably in a range of 1.0 to 2.5 equivalents, and most preferably in a range of 1.4 to 2.5 equivalents to 1.0 equivalent of the amine represented by the formula (3).
  • the use amount of the base falls within this range, the target material can be obtained in a high yield without removing the by-produced alcohol or phenol outside the system, and hence, such is preferred.
  • the use amount of the base is less than 1.0 equivalent, there is a tendency that the reaction does not proceed, and the yield does not increase.
  • the solvent which is used in the aminolysis reaction is preferably an aprotic solvent.
  • the solvent include amide-based solvents, such as N,N-dimethylacetamide, N-methylpyrrolidone, N-ethylpyrrolidone, and N,N-dimethylformamide; sulfur-containing solvents, such as dimethyl sulfoxide; hydrocarbon-based solvents, such as benzene, toluene, and xylene; and halogen-based solvents, such as dichloromethane and dichloroethane.
  • amide-based solvents such as N,N-dimethylacetamide, N-methylpyrrolidone, N-ethylpyrrolidone, and N,N-dimethylformamide
  • sulfur-containing solvents such as dimethyl sulfoxide
  • hydrocarbon-based solvents such as benzene, toluene, and xylene
  • halogen-based solvents such as dichloromethane and
  • N,N-dimethylacetamide, N-methylpyrrolidone, N-ethylpyrrolidone, N,N-dimethylformamide, and dimethyl sulfoxide are preferred, with N,N-dimethylacetamide, N-methylpyrrolidone, N,N-dimethylformamide, and dimethyl sulfoxide being especially preferred.
  • the solvent which is used herein refers to a specified aprotic solvent that is the reaction solvent to be used on the occasion of performing the aminolysis reaction.
  • a solvent existent in the reaction system is a mixed solvent containing other solvent than this aprotic solvent, there is no objection so far as the effects of the present invention are brought.
  • the aprotic solvent to be used herein for the reaction becomes the solvent to be used on the occasion of the reaction as referred to in the present invention.
  • examples of the case where other solvent is existent in such a reaction system include a case where a small amount of the solvent to be caused due to the raw material used is incorporated into the reaction system.
  • the solvent which is incorporated in a small amount for example, in the case where a source material to be used as the raw material is diluted with a solvent different from the solvent on the occasion of performing the aminolysis reaction, when using this raw material, the solvent which dissolves the raw material therein, for example, toluene, or the solvent which dissolves the base to be used as a catalyst (for example, an alcohol in the metal alkoxide), is occasionally partially incorporated into the reaction solvent.
  • the water content in such a reaction solvent is preferably 0.5% by mass or less, and especially preferably 0.1% by mass or less.
  • these aprotic solvents may be used alone; or two or more thereof may be mixed and used as a mixed solvent, and as for a mixing ratio thereof, any arbitrary proportion is adaptable.
  • the use amount of the solvent is in a range of 0.5 to 10.0 equivalents, and preferably in a range of 2.0 to 5.0 equivalents relative to the amine represented by the formula (3), and the concentration of the amine is preferably 50% by mass or less.
  • the target material can be obtained in high purity and high yield.
  • the reaction temperature is generally in a range of -20°C to 140°C, and preferably in a range of 20°C to 90°C.
  • the reaction time is generally in a range of 1 to 10 hours, and preferably in a range of 2 to 5 hours.
  • the reaction in the case where a metal alkoxide is used as the base in an excessive amount as 1.0 to 7.0 equivalents relative to the aforementioned amine, and preferably, the reaction is performed in the aforementioned aprotic solvent, the reaction can be completed even when the alcohol or phenol generated owing to the aminolysis reaction between the ester and the amine is not removed from the reaction system.
  • the reason for this is not elucidated yet, it may be estimated that in the case where the carboxamide as a target material, which is formed along the progress of reaction, takes in a metal ion (e.g., a sodium ion) in the reaction system to form a metal salt, the reaction equilibrium shifts to the direction of carboxamide formation, whereby the reaction is possibly completed without causing a reverse reaction.
  • a metal ion e.g., a sodium ion
  • the resulting pyrazole-4-carboxamide derivative is deposited in the organic layer, whereby the target material can be given in high yield and high purity.
  • the amount of water needed for deposition is about 1.0 to 7.0 in terms of a mass ratio relative to the used solvent, and it is about 10.0 to 180.0 in terms of a mass ratio on a basis of the amine.
  • the pyrazole-4-carboxamide derivative can be given through a simple operation of adding water after completion of the reaction as mentioned above.
  • water is added to the reaction mixture after the end of the reaction to perform washing, and the aqueous layer is separated to remove an unnecessary material from the organic layer containing the target material.
  • the amount of water when performing washing is in a range of 5 to 150 equivalents, and preferably in a range of 10 to 50 equivalents on a basis of the amine represented by the formula (3).
  • the washing can be, for example, performed in the following manner: water is added to the reaction mixture, stirring is performed, and the resultant is allowed to stand, thereby separating the organic layer and the aqueous layer from each other, followed by removing the aqueous layer.
  • an alkali metal hydroxide such as potassium hydroxide and sodium hydroxide, or an alkaline earth metal hydroxide, such as calcium hydroxide can also be added.
  • an alkali metal chloride such as potassium chloride and sodium chloride, or an alkaline earth metal chloride, such as calcium chloride
  • the separation between the organic layer and the aqueous layer can also be made easy owing to a salting effect or the like.
  • the target material after completion of the reaction, by adding water, the target material can be deposited and obtained; however, adoption of a method in which the addition of water is performed in two stages such that water is first added to perform washing and separate the organic layer and the aqueous layer from each other, and water is again added to the separated organic layer to deposit the target material is preferred from the standpoint that an inorganic material (mainly, the alkali metal hydroxide and the like) in the reaction mixture can be removed by water washing and that the purity of the pyrazole-4-carboxamide derivative can be increased.
  • an inorganic material mainly, the alkali metal hydroxide and the like
  • the purity equal to that in the case of performing the liquid separation can be achieved.
  • the amount of water for rinsing is required to be about 2 to 10 times that in the case of liquid separation, so that the use amount of water somewhat increases; however, the purity and yield of the resulting pyrazole-4-carboxamide derivative do not change.
  • the isolation of the target pyrazole-4-carboxamide derivative can be achieved by adding water directly to the reaction mixture after the end of the reaction; or adding water to the organic layer which has been obtained by adding water to the reaction mixture and performing washing and separation, to deposit the pyrazole-4-carboxamine derivative as a crystal, followed by performing solid-liquid separation.
  • the temperature on the occasion of adding water to the reaction mixture after the end of the reaction varies with the reaction temperature, the solubility of the resulting pyrazole-4-carboxamide derivative, and the amount of the organic layer, it may be a temperature at which the target material is not decomposed. In general, the temperature is preferably in a range of about 20°C to 100°C, and more preferably in a range of about 40°C to 90°C.
  • the crystal can be obtained.
  • the separated crystal is rinsed, thereby washing the mother liquid attached to the crystal.
  • the pyrazole-4-carboxamide derivative represented by the formula (1) in a high purity can be obtained.
  • a purification process such as distillation, recrystallization, and column chromatography, is not required at all.
  • R 1 , R 2 , R 3 , and Qx are the same as the contents mentioned previously.
  • Table 1 Compound No. R 1 R 2 R 3 Qx Compound No, R 1 R 2 R 3 Qx 1 CH 3 CF 2 H H Q1 2 CH 3 CF 2 H H Q2 Y 1 n H V CH 2 3 3-CH 3 4 3-F R 4 ,R 5 ,R 6 CH 3 5 2,6-(CH 3 ) 2 9 CH 3 CF 2 H H Q4 Ym 7-F 6 CH 3 CF 2 H H Q3 R 9 ⁇ R 14 H W Y 1 p 10 H Z n T H Cl 7 Y 1 p 11 CH 3 CF 3 H Q5 4-F Z n 3',4'-(Cl) 2 8 Y 1 p G H S Z n 3',4',5'-(F) 3
  • Table 1 Compound No. R 1 R 2 R 3 Qx Compound No, R 1 R 2 R 3 Qx 1 CH 3 CF 2 H H Q1 2 CH 3
  • the structure of the target material was confirmed by means of the 1 H-NMR spectrum measurement at 500 MHz, and an area percentage measured by HPLC was used as the purity.
  • Ethyl 3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylate and ethyl 3-(trifluoromethyl)-1-methyl-1H-pyrazole-4-carboxylate used in the Examples were prepared by the method described in WO 2006/090778 A .
  • the structure of the target material was confirmed by means of the 1 H-NMR spectrum measurement at 500 MHz, and the purity was determined by preparing a calibration curve using a standard material by HPLC and adopting the absolute calibration curve method.
  • the 7-fluoro-1,1,3-trimethyl-4-aminoindane to be used for the reaction was prepared by reference to EP 0654464 A or the like.
  • the reaction mixture was cooled to 73.0°C, and 19.9 g of water was added to the organic layer, and cooling to 0°C was performed, whereby the target 3-difluoromethyl-N-(7-fluoro-1,1,3-trimethyl-4-indanyl)-1-methyl-4-pyrazole carboxamide was deposited as a crystal.
  • the deposited crystal was separated by means of filtration and washed with 50.0 g of water.
  • the yield was 94.0% (on a basis of 3',4'-dichloro-5-fluorobiphenyl-2-ylamine), and the purity was 98.8% (HPLC area percentage), and a purification operation, such as recrystallization, was not needed.
  • the 3',4',5'-trifluorobiphenyl-2-ylamine was prepared by reference to WO 2010/094736 A .
  • the yield was 92.3% (on a basis of 3',4',5'-trifluorobiphenyl-2-ylamine), and the purity was 97.7% (HPLC area percentage), and a purification operation, such as recrystallization, was not needed.
  • the yield was 92.0% (on a basis of the mixture of N-[(1RS,4SR,9RS)-1,2,3,4-tetrahydro-9-isopropyl-1,4-methanonaphthalen-5-yl]amine and N-[(1RS,4SR,9SR)-1,2,3,4-tetrahydro-9-isopropyl-1,4-methanonaphthalen-5-yl] amine), and the purity was 99.5% (the total sum of HPLC area percentages of the syn-form and the anti-form), and a purification operation, such as recrystallization, was not needed.
  • the background art is in general concerned with the usual aminolysis reaction in which a by-produced alcohol or phenol is removed outside the reaction system through fractionation or the like, and the equilibrium is shifted toward the reaction production system, thereby completing the reaction, and it may be said that the treatment after the reaction is also usual one.
  • the present invention is concerned with a technology in which the pyrazole-4-caroxamide derivative can be obtained in high yield and high purity by a simple method in which the reaction can be completed without removing the by-produced alcohol or phenol outside the system, and as for the treatment after the reaction, water is added after the end of the reaction, to deposit a crystal, and thus, it is noted that the present invention is concerned with an extremely simple and safe method.
  • the production method of the present invention is useful as an industrial production method in which the pyrazole-4-carboxamide derivative that is useful as an agricultural fungicide can be obtained in high yield and high purity through a short process and a simple operation.

Description

    Technical Field
  • The present invention relates to a method of producing a pyrazole-4-carboxamide derivative.
  • Background Art
  • Pyrazole-4-carboxamide derivatives are useful as agricultural chemicals or intermediates thereof, and so on. For example, PTL 1 ( WO 2013/186325 A ) describes fluindapyr; PTL 2 ( WO 2003/070705 A ) describes bixafen; PTL 3 ( WO 2006/087343 A ) describes fluxapyroxad; PTL 4 ( WO 2007/115765 A ) describes isopyrazam; PTL 5 ( WO 2007/048556 A ) describes benzovindiflupyr; and PTL 6 ( EP 0737682 A ) describes penthiopyrad. These have excellent effects as an agricultural fungicide and are widely used in the world for controlling crop diseases.
  • As a method which is known as the production method of a carboxamide derivative, a method of allowing an active type of the corresponding carboxylic acid, for example, an acid chloride, to react with an amine to obtain the carboxamide derivative, is described in PTL 2 ( WO 2003/070705 A ), PTL 7 ( WO 2007/009717 A ), and PTL 8 ( WO 2007/031323 A ).
  • In addition, a method of allowing a carboxylic acid and an amine to react with each other in the presence of a condensing agent, such as N,N'-dicyclohexylcarbodiimide and bis(2-oxo-3-oxazolidinyl)phosphoryl chloride, to obtain a carboxamide is described in PTL 3 ( WO 2006/087343 A ) and PTL 9 ( WO 2005/123690 A ).
  • In the aforementioned method, it is needed that after converting the corresponding carboxylic acid ester into a carboxylic acid through hydrolysis, the acid chloride is prepared by using a chlorinating agent, such as thionyl chloride and oxalyl chloride, and there were involved such problems that the number of steps to reach the carboxamide is long, that a reagent which is dangerous in handling for preparation of the acid chloride must be used, and that large quantities of waste acid and waste water come out after the reaction.
  • In addition, in the method of using a condensing agent, in addition to the fact that a hydrolysis step of the carboxylic acid ester is needed similar to the above, there were involved such problems that wastes which are difficultly separated from the target material are generated after the reaction, and that the bis(2-oxazolidinyl)phosphoryl chloride has carcinogenicity and is dangerous in handling.
  • Meanwhile, in an aminolysis reaction capable of obtaining a target carboxamide by allowing a carboxylic acid ester and an amine to react directly with each other, the production process is shortened, and since the acid chlorination is not adopted, it is not needed to use a dangerous reagent, and safety in the operation becomes high. In addition to the above, it becomes possible to reduce wastes, such as waste acid and waste water. Thus, such a method may become an industrially advantageous production method.
  • Examples of the background art of the production method of a pyrazole-4-carboxamide derivative using the aminolysis reaction in the presence of a base include the following patent literatures: PTL 10 ( WO 2012/055864 A ) and PTL 11 ( WO 2012/175511 A ).
  • PTL 10 ( WO 2012/055864 A ) describes that the pyrazole-4-carboxamide derivative can be produced from a pyrazole-4-carboxylic acid ester and an amine by using a bulky non-nucleophilic base, such as potassium tert-butoxide. However, the base is limited to the non-nucleophilic base, and silica gel chromatography is needed for purification of the target material, and therefore, it is hard to say that the foregoing method is an industrial production method.
  • In addition, PTL 11 ( WO 2012/175511 A ) describes that the pyrazole-4-carboxamide derivative can be produced from a pyrazole-4-carboxylic acid ester and an amine by using a metal alkoxide as the base. However, for completion of the reaction, a step of reducing the pressure in the system and removing the by-produced alcohol through azeotropic distillation with toluene as a solvent is needed, and from the standpoint of complicated operation and increase of waste liquids, it is hard to say that the method is advantageous as an industrial production method.
  • Citation List Patent Literature
  • Summary of Invention Technical Problem
  • The present invention is one solving the aforementioned problems involved in the background art and is to provide an industrial production method in which a pyrazole-4-carboxamide derivative that is useful as an agricultural fungicide can be obtained simply and in high yield and high purity as compared with the conventional method.
  • Solution to Problem
  • The present inventors made extensive and intensive investigations regarding a method of producing a pyrazole-4-carboxamide derivative of the formula (1) through an aminolysis reaction of a pyrazole carboxylic acid ester of the formula (2) and an amine of the formula (3) in a solvent in the presence of a base according to the following reaction formula (A). As a result, surprisingly, it has been found that the reaction can be completed without removing a by-produced alcohol or phenyl, which is needed to be removed outside the system in the general aminolysis reaction, outside the system, thereby leading to accomplishment of the present invention. Specifically, the present invention is to provide an industrial production method in which not only the pyrazole-4-carboxamide derivative represented by the formula (1) is obtained by a simple operation and in high yield and high purity, but also it is possible to reduce the quantities of waste acid and waste water.
    Figure imgb0001
  • R, R1, R2, R3, and Qx in the formulae (1), (2), and (3) are respectively described later.
  • Advantageous Effects of Invention
  • In accordance with the production method of a pyrazole-4-carboxamide derivative according to the present invention, it is possible to obtain the pyrazole-4-carboxamide derivative which is useful as an agricultural fungicide, simply and in high yield and high purity as compared with the conventional method by a short process and a simple operation, and the production method of the present invention can be adopted as an industrial production method.
  • Description of Invention
  • The invention is defined in the appended claims. Embodiments not encompassed by the claims are provided for reference purposes.
  • The method of producing a pyrazole-4-carboxamide derivative according to the present invention is hereunder specifically described on a basis of the reaction formula (A).
  • The present invention relates to a production method of a pyrazole-4-carboxamide derivative represented by the formula (1) through an aminolysis reaction of a pyrazole-4-carboxylic acid ester of the formula (2) and an amine of the formula (3) in a solvent in the presence of a base according to the reaction formula (A) and is an invention of the production method in which on the occasion of reaction, the reaction can be completed without removing a by-produced alcohol or phenol outside the reaction system.
  • The pyrazole-4-carboxamide derivative obtained by the aforementioned reaction is a compound represented by the formula (1). In addition, the pyrazole-4-carboxamide derivative represented by the formula (1) includes not only a single optical isomer and a diastereoisomer but also morphologies of a racemic mixture, a diastereoisomer mixture, and a partially separated mixture of such a compound, caused by the structure of the amine represented by the formula (2).
  • Here, the racemic mixture and the diastereoisomer mixture each mean a mixture of isomers thereof (racemate and diastereomer); and the partially separated mixture means a mixture remained resulting from separation of a part of isomers from isomers constituting a racemic mixture and a diastereoisomer mixture (for example, in the case of a racemate, a mixture of isomers in which as a result of separation of a part of the R-form or the S-form, a ratio of the R-form and S-form has changed from a typical value of 1/1 to a value of not 1/1).
  • The compound represented by the formula (1) is one mentioned below.
    Figure imgb0002
  • In the formula (1), R1 is a hydrogen atom, a C1-C4 alkyl group, a C1-C4 haloalkyl group, a C3-C6 cycloalkyl group, a C3-C6 halocycloalkyl group, a C1-C4 alkoxy group, a C1-C4 haloalkoxy group, a C1-C4 alkylthio group, a C1-C4 haloalkylthio group, an aralkyl group, or an aryl group, preferably a C1-C4 alkyl group, and especially preferably a methyl group.
  • R2 is a hydrogen atom, a halogen atom, a C1-C4 alkyl group, a C1-C4 haloalkyl group, a C3-C6 cycloalkyl group, a C3-C6 halocycloalkyl group, a C1-C4 alkoxy group, a C1-C4 haloalkoxy group, a C1-C4 alkylthio group, a C1-C4 haloalkylthio group, an aralkyl group, or an aryl group, preferably a C1-C4 haloalkyl group, and especially preferably a difluoromethyl group or a trifluoromethyl group.
  • R3 is a hydrogen atom, a halogen atom, a C1-C4 alkyl group, a C1-C4 haloalkyl group, a C3-C6 cycloalkyl group, a C3-C6 halocycloalkyl group, a C1-C4 alkoxy group, a C1-C4 haloalkoxy group, a C1-C4 alkylthio group, a C1-C4 haloalkylthio group, an aralkyl group, or an aryl group, and especially preferably a hydrogen atom.
  • Qx that is an amine residue is one mentioned later.
  • The pyrazole-4-carboxylic acid ester represented by the formula (2), which is one of the starting substances, is one mentioned below.
    Figure imgb0003
  • In the formula (2), R1 is a hydrogen atom, a C1-C4 alkyl group, a C1-C4 haloalkyl group, a C3-C6 cycloalkyl group, a C3-C6 halocycloalkyl group, a C1-C4 alkoxy group, a C1-C4 haloalkoxy group, a C1-C4 alkylthio group, a C1-C4 haloalkylthio group, an aralkyl group, or an aryl group, preferably a C1-C4 alkyl group, and especially preferably a methyl group.
  • R2 is a hydrogen atom, a halogen atom, a C1-C4 alkyl group, a C1-C4 haloalkyl group, a C3-C6 cycloalkyl group, a C3-C6 halocycloalkyl group, a C1-C4 alkoxy group, a C1-C4 haloalkoxy group, a C1-C4 alkylthio group, a C1-C4 haloalkylthio group, an aralkyl group, or an aryl group, preferably a C1-C4 haloalkyl group, and especially preferably a difluoromethyl group or a trifluoromethyl group.
  • R3 is a hydrogen atom, a halogen atom, a C1-C4 alkyl group, a C1-C4 haloalkyl group, a C3-C6 cycloalkyl group, a C3-C6 halocycloalkyl group, a C1-C4 alkoxy group, a C1-C4 haloalkoxy group, a C1-C4 alkylthio group, a C1-C4 haloalkylthio group, an aralkyl group, or an aryl group, and especially preferably a hydrogen atom.
  • R is a C1-C4 alkyl group or an optionally substituted phenyl group, preferably a C1-C4 alkyl group, and especially preferably an ethyl group.
  • The amine represented by the formula (3), which is to be allowed to react with the pyrazole-4-carboxylic acid ester represented by the formula (2) is one mentioned below.

            H2N-Qx     (3)

  • In the formula (3), Qx represents any substituent (amine residue) of Q1, Q2, Q3, Q4, Q5, and Q6.
    Figure imgb0004
    Figure imgb0005
  • In Q1, R4, R5, and R6 are the same as or different from each other and are each a C1-C4 alkyl group, a C1-C4 haloalkyl group, a C3-C6 cycloalkyl group, or a C3-C6 halocycloalkyl group, provided that R5 and R6 may be bonded to each other to form a C3-C6 cycloalkyl group; and preferably a C1-C4 alkyl group. In particular, it is preferred that R4, R5, and R6 are each a methyl group.
  • V represents CH(R7), N(R8), an oxygen atom, or a sulfur atom; and R7 and R8 are each a hydrogen atom, a C1-C4 alkyl group, a C1-C4 haloalkyl group, a C3-C6 cycloalkyl group, or a C3-C6 halocycloalkyl group. In particular, it is preferred that in CH(R7), R7 is a hydrogen atom.
  • Y represents a halogen atom, a C1-C4 alkyl group, a C1-C4 haloalkyl group, a C1-C4 alkoxy group, a C1-C4 haloalkoxy group, an SH group, a C1-C4 alkylthio group, or a C1-C4 haloalkylthio group, preferably a halogen atom, and especially preferably a fluorine atom.
  • m is an integer of 0 to 3, preferably 0 or 1, and especially preferably 1. In addition, the substitution position of the fluorine atom is especially preferably the 7-position of the indane-amine.
  • In Q2, Y1 represents a hydrogen atom, a halogen atom, a C1-C6 alkyl group, a C1-C6 haloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, an SH group, a C1-C6 alkylthio group, or a C1-C6 haloalkylthio group, and preferably a hydrogen atom, a C1-C6 alkyl group, or a halogen atom.
  • n represents an integer of 1 to 5, and when n is 2, 3, 4, or 5, then Y1's may be the same as or different from each other.
  • In Q3, Y1 and Z each represent a hydrogen atom, a halogen atom, a C1-C6 alkyl group, a C1-C6 haloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, an SH group, a C1-C6 alkylthio group, or a C1-C6 haloalkylthio group, and preferably a hydrogen atom or a halogen atom.
  • p represents an integer of 1 to 4, and when p is 2, 3, or 4, then Y1's may be the same as or different from each other.
  • n represents an integer of 1 to 5, and when n is 2, 3, 4, or 5, then Z's may be the same as or different from each other.
  • In Q4, R9, R10, R11, R12, R13, and R14 are the same as or different from each other and each represent a hydrogen atom, a halogen atom, a C1-C6 alkyl group, a C1-C6 haloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, an SH group, a C1-C6 alkylthio group, or a C1-C6 haloalkylthio group, and preferably a hydrogen atom or a C1-C6 alkyl group. In addition, R11 and R12 may be bonded to each other to form a C3-C6 cycloalkyl group and R13 and R14 may be bonded to each other to form a C3-C6 cycloalkyl group.
  • W represents a methylene group, a methine group substituted with a C1-C6 haloalkyl group, or a terminal end-substituted vinyl group represented by the formula (4).
    Figure imgb0006
  • In the formula, T represents a C1-C6 haloalkyl group or a halogen atom, and preferably a chlorine atom.
  • In Q5, Y1 represents a hydrogen atom, a halogen atom, a C1-C6 alkyl group, a C1-C6 haloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, an SH group, a C1-C6 alkylthio group, or a C1-C6 haloalkylthio group, and preferably a C1-C6 alkyl group.
  • m represents an integer of 1 to 3, and when m is 2 or 3, then Y1's may be the same as or different from each other.
  • G represents an oxygen atom, a sulfur atom, or N(R15), and R15 represents a hydrogen atom or a C1-C6 alkyl group, and G is preferably a sulfur atom.
  • In Q6, Y1 represents a hydrogen atom, a halogen atom, a C1-C6 alkyl group, a C1-C6 haloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, an SH group, a C1-C6 alkylthio group, or a C1-C6 haloalkylthio group, and preferably a C1-C6 alkyl group.
  • m represents an integer of 1 to 3, and when m is 2 or 3, then Y1's may be the same as or different from each other.
  • G represents an oxygen atom, a sulfur atom, or N(R15), and R15 represents a hydrogen atom or a C1-C6 alkyl group, and G is preferably a sulfur atom.
  • Examples of the pyrazole-4-carboxamide derivative represented by the formula (1) include:
    • 3-difluoromethyl-N-(7-fluoro-1,1,3-trimethyl-4-indanyl)-1-methyl-4-pyrazole carboxamide: a general name: fluindapyr,
    • 3-(difluoromethyl)-1-methyl-N-(3',4'-dichloro-5-fluorobiphenyl-2-yl)-pyrazole-4-carboxamide: a general name: bixafen,
    • 3-(difluoromethyl)-1-methyl-N-(3',4',5'-trifluorobipenyl)-pyrazole-4-carboxamide: a general name: fluxapyroxad,
    • a mixture of a syn-form: 3-(difluoromethyl)-1-methyl-N-((1RS,4SR,9RS)-1,2,3,4-tetrahydro-9-isopropyl-1,4-methanonaphthalen-5-yl)pyrazole-4-carboxamide and an anti-form: 3-(difluoromethyl)-1-methyl-N-((1RS,4SR,9SR)-1,2,3,4-tetrahydro-9-isopropyl-1,4-methanonaphthalen-5-yl)pyrazole-4-carboxamide: a general name: isopyrazam,
    • 3-(difluoromethyl)-1-methyl-N-(9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl)pyrazole-4-carboxamide: a general name: benzovindiflupyr, and
    • (RS)-N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide: a general name: penthiopyrad.
  • Examples of the pyrazole-4-carboxylic acid ester represented by the formula (2) and the amine represented by the formula (3), all of which are used for the production, include compounds having a substituent corresponding to the pyrazole-4-carboxamide derivative represented by the formula (1), respectively.
  • The production method of the pyrazole-4-carboxamide derivative of the present invention is a method of producing the pyrazole-4-carboxamide derivative represented by the formula (1) through an aminolysis reaction of the pyrazole-4-carboxylic acid ester represented by the formula (2) and the amine represented by the formula (3) in a solvent in the presence of a base and is characterized such that the reaction is completed without removing the by-produced alcohol or phenol outside the system.
  • In the present invention, in the aminolysis reaction, as for a charging ratio of the pyrazole-4-carboxylic acid ester represented by the formula (2) and the amine represented by the formula (3), the amount of the pyrazole-4-carboxylic acid ester is in a range of 1.0 to 2.0 equivalents, and preferably in a range of 1.0 to 1.5 equivalents to 1.0 equivalent of the amine.
  • In the present invention, in the aminolysis reaction, the base to be used is preferably a metal alkoxide, and more preferably a non-bulky metal alkoxide. Specifically, examples thereof include lithium methoxide, lithium ethoxide, sodium methoxide, sodium ethoxide, potassium methoxide, and potassium ethoxide, with sodium methoxide and sodium ethoxide being especially preferred.
  • The use amount of the base is preferably in a range of 1.0 to 7.0 equivalents, more preferably in a range of 1.0 to 5.0 equivalents, still more preferably in a range of 1.0 to 3.0 equivalents, especially preferably in a range of 1.0 to 2.5 equivalents, and most preferably in a range of 1.4 to 2.5 equivalents to 1.0 equivalent of the amine represented by the formula (3). When the use amount of the base falls within this range, the target material can be obtained in a high yield without removing the by-produced alcohol or phenol outside the system, and hence, such is preferred. In the case where the use amount of the base is less than 1.0 equivalent, there is a tendency that the reaction does not proceed, and the yield does not increase.
  • In the present invention, the solvent which is used in the aminolysis reaction is preferably an aprotic solvent. Specific examples of the solvent include amide-based solvents, such as N,N-dimethylacetamide, N-methylpyrrolidone, N-ethylpyrrolidone, and N,N-dimethylformamide; sulfur-containing solvents, such as dimethyl sulfoxide; hydrocarbon-based solvents, such as benzene, toluene, and xylene; and halogen-based solvents, such as dichloromethane and dichloroethane. In addition, of these aprotic solvents, N,N-dimethylacetamide, N-methylpyrrolidone, N-ethylpyrrolidone, N,N-dimethylformamide, and dimethyl sulfoxide are preferred, with N,N-dimethylacetamide, N-methylpyrrolidone, N,N-dimethylformamide, and dimethyl sulfoxide being especially preferred.
  • The solvent which is used herein refers to a specified aprotic solvent that is the reaction solvent to be used on the occasion of performing the aminolysis reaction. However, in the case of using this aprotic solvent, even when a solvent existent in the reaction system is a mixed solvent containing other solvent than this aprotic solvent, there is no objection so far as the effects of the present invention are brought. The aprotic solvent to be used herein for the reaction becomes the solvent to be used on the occasion of the reaction as referred to in the present invention. In this case, examples of the case where other solvent is existent in such a reaction system include a case where a small amount of the solvent to be caused due to the raw material used is incorporated into the reaction system.
  • As the solvent which is incorporated in a small amount, for example, in the case where a source material to be used as the raw material is diluted with a solvent different from the solvent on the occasion of performing the aminolysis reaction, when using this raw material, the solvent which dissolves the raw material therein, for example, toluene, or the solvent which dissolves the base to be used as a catalyst (for example, an alcohol in the metal alkoxide), is occasionally partially incorporated into the reaction solvent.
  • The water content in such a reaction solvent is preferably 0.5% by mass or less, and especially preferably 0.1% by mass or less. In addition, these aprotic solvents may be used alone; or two or more thereof may be mixed and used as a mixed solvent, and as for a mixing ratio thereof, any arbitrary proportion is adaptable.
  • The use amount of the solvent is in a range of 0.5 to 10.0 equivalents, and preferably in a range of 2.0 to 5.0 equivalents relative to the amine represented by the formula (3), and the concentration of the amine is preferably 50% by mass or less. In the case of performing the reaction by using the solvent under such a condition, the target material can be obtained in high purity and high yield.
  • In the present invention, in the aminolysis reaction, the reaction temperature is generally in a range of -20°C to 140°C, and preferably in a range of 20°C to 90°C.
  • In the present invention, in the aminolysis reaction, the reaction time is generally in a range of 1 to 10 hours, and preferably in a range of 2 to 5 hours.
  • In the present invention, in the case where a metal alkoxide is used as the base in an excessive amount as 1.0 to 7.0 equivalents relative to the aforementioned amine, and preferably, the reaction is performed in the aforementioned aprotic solvent, the reaction can be completed even when the alcohol or phenol generated owing to the aminolysis reaction between the ester and the amine is not removed from the reaction system. Although, the reason for this is not elucidated yet, it may be estimated that in the case where the carboxamide as a target material, which is formed along the progress of reaction, takes in a metal ion (e.g., a sodium ion) in the reaction system to form a metal salt, the reaction equilibrium shifts to the direction of carboxamide formation, whereby the reaction is possibly completed without causing a reverse reaction. In addition, in this case, it may also be considered to be one of causes that taking-in of a metal ion by the carboxamide is promoted by an interaction with the solvent to be used for the reaction.
  • As a result, by adding water to the resulting reaction mixture and performing cooling, the resulting pyrazole-4-carboxamide derivative is deposited in the organic layer, whereby the target material can be given in high yield and high purity.
  • The amount of water needed for deposition is about 1.0 to 7.0 in terms of a mass ratio relative to the used solvent, and it is about 10.0 to 180.0 in terms of a mass ratio on a basis of the amine.
  • In the present invention, the pyrazole-4-carboxamide derivative can be given through a simple operation of adding water after completion of the reaction as mentioned above. However, prior to this, it is preferred that before depositing the pyrazole-4-carboxamide derivative by the addition of water to the reaction mixture after the end of the reaction, water is added to the reaction mixture after the end of the reaction to perform washing, and the aqueous layer is separated to remove an unnecessary material from the organic layer containing the target material. The amount of water when performing washing is in a range of 5 to 150 equivalents, and preferably in a range of 10 to 50 equivalents on a basis of the amine represented by the formula (3). The washing can be, for example, performed in the following manner: water is added to the reaction mixture, stirring is performed, and the resultant is allowed to stand, thereby separating the organic layer and the aqueous layer from each other, followed by removing the aqueous layer.
  • On the occasion of separating the organic layer and the aqueous layer from each other, in order to enhance the separation state, an alkali metal hydroxide, such as potassium hydroxide and sodium hydroxide, or an alkaline earth metal hydroxide, such as calcium hydroxide can also be added. In addition, by adding an alkali metal chloride, such as potassium chloride and sodium chloride, or an alkaline earth metal chloride, such as calcium chloride, the separation between the organic layer and the aqueous layer can also be made easy owing to a salting effect or the like.
  • In summary, in the present invention, after completion of the reaction, by adding water, the target material can be deposited and obtained; however, adoption of a method in which the addition of water is performed in two stages such that water is first added to perform washing and separate the organic layer and the aqueous layer from each other, and water is again added to the separated organic layer to deposit the target material is preferred from the standpoint that an inorganic material (mainly, the alkali metal hydroxide and the like) in the reaction mixture can be removed by water washing and that the purity of the pyrazole-4-carboxamide derivative can be increased.
  • However, even in the case where the liquid separation between the organic layer and the aqueous layer as mentioned above is not performed, when a crystal of the pyrazole-4-caroxamide derivative which has been deposited by the addition of water is rinsed with water, the purity equal to that in the case of performing the liquid separation can be achieved. In this case, the amount of water for rinsing is required to be about 2 to 10 times that in the case of liquid separation, so that the use amount of water somewhat increases; however, the purity and yield of the resulting pyrazole-4-carboxamide derivative do not change.
  • As mentioned above, the isolation of the target pyrazole-4-carboxamide derivative can be achieved by adding water directly to the reaction mixture after the end of the reaction; or adding water to the organic layer which has been obtained by adding water to the reaction mixture and performing washing and separation, to deposit the pyrazole-4-carboxamine derivative as a crystal, followed by performing solid-liquid separation. In addition, though the temperature on the occasion of adding water to the reaction mixture after the end of the reaction varies with the reaction temperature, the solubility of the resulting pyrazole-4-carboxamide derivative, and the amount of the organic layer, it may be a temperature at which the target material is not decomposed. In general, the temperature is preferably in a range of about 20°C to 100°C, and more preferably in a range of about 40°C to 90°C.
  • Subsequently, by performing cooling, the crystal can be obtained. On this occasion, regardless of whether or not performing the washing and separation, in all of the methods, it is preferred that the separated crystal is rinsed, thereby washing the mother liquid attached to the crystal.
  • By drying the resulting crystal, the pyrazole-4-carboxamide derivative represented by the formula (1) in a high purity can be obtained. On this occasion, a purification process, such as distillation, recrystallization, and column chromatography, is not required at all.
  • Examples
  • The present invention is hereunder described in detail on a basis of Examples, but it should be construed that the present invention is not limited by these Examples.
  • The pyrazole-4-carboxamide derivatives represented by the formula (1), which were prepared according to the present invention, are shown in Table 1.
    Figure imgb0007
  • In the formula, R1, R2, R3, and Qx are the same as the contents mentioned previously. Table 1
    Compound No. R1 R2 R3 Qx Compound No, R1 R2 R3 Qx
    1 CH3 CF2H H Q1 2 CH3 CF2H H Q2
    Figure imgb0008
    Figure imgb0009
    Y1n
    H
    V CH2 3 3-CH3
    4 3-F
    R4,R5,R6 CH3 5 2,6-(CH3)2
    9 CH3 CF2H H Q4
    Ym
    Figure imgb0010
    7-F
    6 CH3 CF2H H Q3
    Figure imgb0011
    R9∼R14
    H
    W
    Figure imgb0012
    Y1 p 10
    Figure imgb0013
    H
    Zn T
    H Cl
    7 Y1 p 11 CH3 CF3 H Q5
    4-F
    Figure imgb0014
    Zn
    3',4'-(Cl)2
    8 Y1 p G
    H S
    Zn
    Figure imgb0015
    3',4',5'-(F)3
    The production of the 4-pyrazolecarboxamides enumerated in Table 1 is hereunder described by reference to the Examples of the present invention, but it should be construed that the present invention is not limited thereto.
  • The structure of the target material was confirmed by means of the 1H-NMR spectrum measurement at 500 MHz, and an area percentage measured by HPLC was used as the purity.
  • Ethyl 3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylate and ethyl 3-(trifluoromethyl)-1-methyl-1H-pyrazole-4-carboxylate used in the Examples were prepared by the method described in WO 2006/090778 A .
  • With respect to the amine, those which are commercially available were purchased and used, whereas those which are not commercially available were prepared following the reference literatures and used. The reference literatures regarding the amine preparation method are described in the following Examples.
  • The structure of the target material was confirmed by means of the 1H-NMR spectrum measurement at 500 MHz, and the purity was determined by preparing a calibration curve using a standard material by HPLC and adopting the absolute calibration curve method.
  • Example 1
  • Synthesis of 3-difluoromethyl- N- (7 -fluoro -1,1,3-trimethyl-4-indanyl)-1-methyl-4-pyrazole carboxamide (Compound No. 1: a general name: fluindapyr) Synthesis Example 1-1
  • To 33.9 mL of N-methylpyrrolidone in a 200-mL four-necked flask, 79.8 g (82.6 mmol) of a 21.1% by mass toluene solution of ethyl 3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylate and 64.9 g (70.4 mmol) of a 21.0% by mass toluene solution of 7-fluoro-1,1,3-trimethyl-4-aminoindane were added.
  • The 7-fluoro-1,1,3-trimethyl-4-aminoindane to be used for the reaction was prepared by reference to EP 0654464 A or the like.
  • Subsequently, the contents were subjected to vacuum concentration to recover 105.8 g of toluene, thereby obtaining a N-methylpyrrolidone solution of ethyl 3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylate and 7-fluoro-1,1,3-trimethyl-4-aminoindane in which 6.8% mass of toluene remained. Subsequently, 10.49 g (154.2 mmol) of sodium ethoxide was added, and the contents were stirred at an internal temperature of 83.6°C for 1.5 hours. The reaction mixture was cooled to 70°C, and then, 34.3 g of water was added to wash the organic layer. After separating the aqueous layer, 104.61 g of water was added to the organic layer, and cooling to 10°C was performed, whereby the target 3-difluoromethyl-N-(7-fluoro-1,1,3-trimethyl-4-indanyl)-1-methyl-4-pyrazole carboxamide was deposited as a crystal. The deposited crystal was separated by means of filtration and washed with 12.3 g of water.
  • The crystal after washing was dried. As a result, 24.4 g (66.7 mmol) of 3-difluoromethyl-N-(7-fluoro-1,1,3-trimethyl-4-indanyl)-1-methyl-4-pyrazole carboxamide was obtained as a white crystal. The yield was 94.5%, and the purity was 96.0%, and a purification operation, such as recrystallization, was not needed. Melting point: 170.8°C
    1H-NMR (1H resonance frequency: 500 MHz, measurement solvent: CDCl3, internal standard substance: tetramethylsilane)
  • δ value (ppm): 1.43 (3H,d), 1.38 (3H,s), 1.44 (3H,s), 1.66 (1H,dd), 2.21 (1H,dd), 3.38 (1H,m), 3.93 (3H,s), 6.81 (1s,bs), 6.95 (1H,t), 6.70 (1H,m), 7.81 (1H,bs), 8.03 (1H,bs)
  • Synthesis Example 1-2
  • To 8.65 mL of N-methylpyrrolidone in a 100-mL four-necked flask, 31.84 g (32.9 mmol) of a 21.1% by mass toluene solution of ethyl 3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylate and 51.74 g (30.0 mmol) of a 11.2% by mass toluene solution of 7-fluoro-1,1,3-trimethyl-4-aminoindane were added.
  • The contents were subjected to vacuum concentration to recover 59.4 g of toluene, thereby obtaining a N-methylpyrrolidone solution of ethyl 3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylate and 7-fluoro-1,1,3-trimethyl-4-aminoindane in which 13.3% mass of toluene remained. Subsequently, 2.97 g (43.6 mmol) of sodium ethoxide was added, and the contents were stirred at an internal temperature of 75.2°C for 6.0 hours. The reaction mixture was cooled to 73.0°C, and 19.9 g of water was added to the organic layer, and cooling to 0°C was performed, whereby the target 3-difluoromethyl-N-(7-fluoro-1,1,3-trimethyl-4-indanyl)-1-methyl-4-pyrazole carboxamide was deposited as a crystal. The deposited crystal was separated by means of filtration and washed with 50.0 g of water.
  • The crystal after washing was dried. As a result, 9.64 g (26.4 mmol) of 3-difluoromethyl-N-(7-fluoro-1,1,3-trimethyl-4-indanyl)-1-methyl-4-pyrazole carboxamide was obtained as a white crystal. The yield was 88.1%, and the purity was 96.3%, and a purification operation, such as recrystallization, was not needed. Melting point: 170.8°C
    1H-NMR (1H resonance frequency: 500 MHz, measurement solvent: CDCl3, internal standard substance: tetramethylsilane)
  • δ value (ppm): 1.43 (3H,d), 1.38 (3H,s), 1.44 (3H,s), 1.66 (1H,dd), 2.21 (1H,dd), 3.38 (1H,m), 3.93 (3H,s), 6.81 (1s,bs), 6.95 (1H,t), 6.70 (1H,m), 7.81 (1H,bs), 8.03 (1H,bs)
  • Synthesis Example 1-3
  • First of all, from the toluene solution of ethyl 3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylate which was used as the starting raw material in Synthesis Example 1-1, the toluene was removed with an evaporator, to obtain ethyl 3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylate. The toluene was not substantially contained in the resulting concentrate, and the toluene content was almost 0%. From the toluene solution of 7-fluoro-1,1,3-trimethyl-4-aminoindane, the toluene was removed in a similar manner, to obtain 7-fluoro-1,1,3-trimethyl-4-aminoindane. The toluene was not substantially contained in the resulting concentrate, and the toluene content was almost 0%.
  • Subsequently, using the thus obtained ethyl 3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylate and 7-fluoro -1,1,3-trimethyl-4-aminoindane, synthesis of 3-difluoromethyl-N-(7-fluoro-1,1,3-trimethyl-4-indanyl)-1-methyl-4-pyrazole carboxamide was performed in the following manner.
  • To 43.0 mL of N-methylpyrrolidone in a 200-mL four-necked flask equipped with a cooling water refluxing tube, 20.2 g (98.9 mmol) of ethyl 3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylate and 17.4 g (90.0 mmol) of 7-fluoro-1,1,3-trimethyl-4-aminoindane were added.
  • The contents were stirred to form a solution, to which was then added 13.5 g (198.2 mmol) of sodium ethoxide, followed by stirring at an internal temperature of 48.9°C for 5.5 hours. The reaction mixture was cooled to 45°C, and then, 44.7 g of water was added to wash the organic layer. After separating the aqueous layer, 73.7 g of water was added to the organic layer, and cooling to 10°C was performed, whereby the target 3-difluoromethyl-N-(7-fluoro-1,1,3-trimethyl-4-indanyl)-1-methyl-4-pyrazole carboxamide was deposited as a crystal. The deposited crystal was separated by means of filtration and washed with 15.8 g of water.
  • The crystal after washing was dried. As a result, 30.6 g (83.8 mmol) of 3-difluoromethyl-N-(7-fluoro-1,1,3-trimethyl-4-indanyl)-1-methyl-4-pyrazole carboxamide was obtained as a white crystal. The yield was 93.0%, and the purity was 96.2%, and a purification operation, such as recrystallization, was not needed. Melting point: 170.8°C
    1H-NMR (1H resonance frequency: 500 MHz, measurement solvent: CDCl3, internal standard substance: tetramethylsilane)
  • δ value (ppm): 1.43 (3H,d), 1.38 (3H,s), 1.44 (3H,s), 1.66 (1H,dd), 2.21 (1H,dd), 3.38 (1H,m), 3.93 (3H,s), 6.81 (1s,bs), 6.95 (1H,t), 6.70 (1H,m), 7.81 (1H,bs), 8.03 (1H,bs)
  • Synthesis Example 1-4
  • Using the ethyl 3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylate and 7-fluoro-1,1,3-trimethyl-4-aminoindane as prepared in Synthesis Example 1-3, synthesis of 3-difluoromethyl- N-(7-fluoro-1,1,3-trimethyl-4-indanyl)-1-methyl-4-pyrazole carboxamide was performed in the following manner.
  • To 14.1 mL of N,N-dimethylacetamide in a 100-mL four-necked flask equipped with a cooling water refluxing tube, 6.86 g (33.3 mmol) of ethyl 3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylate and 5.80 g (30.0 mmol) of 7-fluoro-1,1,3-trimethyl-4-aminoindane were added.
  • The contents were stirred to form a solution, to which was then added 4.6 g (67.6 mmol) of sodium ethoxide, followed by stirring at an internal temperature of 85°C for 1.0 hour.
  • To the resulting reaction mixture, 32.0 g of water was added, and cooling to 8°C was performed, whereby the target 3-difluoromethyl-N-(7-fluoro-1,1,3-trimethyl-4-indanyl)-1-methyl-4-pyrazole carboxamide was deposited as a crystal. The deposited crystal was separated by means of filtration and washed with 25.0 g of water.
  • The crystal after washing was dried. As a result, 9.9 g (27.4 mmol) of 3-difluoromethyl-N-(7-fluoro-1,1,3-trimethyl-4-indanyl)-1-methyl-4-pyrazole carboxamide was obtained as a white crystal. The yield was 91.4%, and the purity was 97.3%, and a purification operation, such as recrystallization, was not needed. Melting point: 170.8°C
    1H-NMR (1H resonance frequency: 500 MHz, measurement solvent: CDCl3, internal standard substance: tetramethylsilane)
  • δ value (ppm): 1.43 (3H,d), 1.38 (3H,s), 1.44 (3H,s), 1.66 (1H,dd), 2.21 (1H,dd), 3.38 (1H,m), 3.93 (3H,s), 6.81 (1s,bs), 6.95 (1H,t), 6.70 (1H,m), 7.81 (1H,bs), 8.03 (1H,bs)
  • Synthesis Example 1-5
  • Using the ethyl 3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylate and 7-fluoro-1,1,3-trimethyl-4-aminoindane as prepared in Synthesis Example 1-3, synthesis of 3-difluoromethyl-N-(7-fluoro-1,1,3-trimethyl-4-indanyl)-1-methyl-4-pyrazole carboxamide was performed in the following manner.
  • To 10.7 mL of dimethyl sulfoxide in a 100-mL four-necked flask equipped with a cooling water refluxing tube, 6.7 g (32.8 mmol) of ethyl 3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylate and 5.8 g (30.0 mmol) of 7-fluoro-1,1,3-trimethyl-4-aminoindane were added.
  • The contents were stirred to form a solution, to which was then added 4.6 g (67.6 mmol) of sodium ethoxide, followed by stirring at an internal temperature of 84°C for 1.0 hour.
  • To the resulting reaction mixture, 32.8 g of water was added, and cooling to 10°C was performed, whereby the target 3-difluoromethyl-N-(7-fluoro-1,1,3-trimethyl-4-indanyl)-1-methyl-4-pyrazole carboxamide was deposited as a crystal. The deposited crystal was separated by means of filtration and washed with 50.0 g of water.
  • The crystal after washing was dried. As a result, 10.3 g (28.2 mmol) of 3-difluoromethyl-N-(7-fluoro-1,1,3-trimethyl-4-indanyl)-1-methyl-4-pyrazole carboxamide was obtained as a white crystal. The yield was 94.1%, and the purity was 96.3%, and a purification operation, such as recrystallization, was not needed. Melting point: 170.8°C
    1H-NMR (1H resonance frequency: 500 MHz, measurement solvent: CDCl3, internal standard substance: tetramethylsilane)
  • δ value (ppm): 1.43 (3H,d), 1.38 (3H,s), 1.44 (3H,s), 1.66 (1H,dd), 2.21 (1H,dd), 3.38 (1H,m), 3.93 (3H,s), 6.81 (1s,bs), 6.95 (1H,t), 6.70 (1H,m), 7.81 (1H,bs), 8.03 (1H,bs)
  • Reference Example 1-1
  • As an example of the conventional method, an example of performing the synthesis according to the method described in PTL 10 ( WO 2012/055864 A ) is shown as Reference Example 1-1.
  • Preparation of 3-difluoromethyl-N-(7-fluoro-1,1,3-trimethyl-4-indanyl)-1-methyl-4-pyrazole carboxamide
  • To 48.8 mL of tetrahydrofuran in a 100-mL four-necked flask equipped with a cooling water refluxing tube, 6.2 g (30.3 mmol) of ethyl 3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylate and 5.8 g (30.0 mmol) of 7-fluoro-1,1,3-trimethyl-4-aminoindane were added.
  • The contents were stirred to form a solution, and subsequently, a suspension liquid having added 5.2 g (45.0 mmol) of tert-butoxypotassium and 73.0 mL of tetrahydrofuran added in a 200-mL four-necked flask equipped with a cooling water refluxing tube was dropped, followed by stirring at an internal temperature of 25°C for 5.0 hours.
  • To the reaction mixture, 50.5 g of water and 156.8 g of ethyl acetate were added, and the organic layer was extracted twice. The extracted organic layer was washed with 29.4 g of water and 40.0 g of a saturated saline solution, and then, the organic layer was concentrated.
  • The residue was purified by means of silica gel chromatography (SiO2; hexane/ethyl acetate = 1/1), to obtain 7.82 g (21.0 mmol) of the target 3-difluoromethyl-N-(7-fluoro-1,1,3-trimethyl-4-indanyl)-1-methyl-4-pyrazole carboxamide as a white crystal. The yield was 70.0%, and the purity was 94.4%. Melting point: 170.3°C
    1H-NMR (1H resonance frequency: 500 MHz, measurement solvent: CDCl3, internal standard substance: tetramethylsilane)
  • δ value (ppm): 1.43 (3H,d), 1.38 (3H,s), 1.44 (3H,s), 1.66 (1H,dd), 2.21 (1H,dd), 3.38 (1H,m), 3.93 (3H,s), 6.81 (1s,bs), 6.95 (1H,t), 6.70 (1H,m), 7.81 (1H,bs), 8.03 (1H,bs)
  • In the light of the above, it is noted that in the synthesis method according to the present invention, on the occasion of the reaction, it is not needed to remove the by-produced alcohol or phenol outside the reaction system, to allow the reaction to proceed while shifting the equilibrium toward the reaction production system as in Reference Example 1-1, and thus, the reaction can be completed without removing the by-produced alcohol or phenol outside the reaction system; and moreover, on the occasion of the treatment, such as isolation, after the reaction, an operation, such as extraction, is not needed, and the pyrazole-4-carboxamide derivative can be obtained in high yield and high purity by an extremely simple method in which after completion of the reaction, water is added, cooling is performed to deposit a crystal, and the crystal is subjected to solid-liquid separation.
  • Example 2 Synthesis of 3-(difluoromethyl)-N-phenyl-1-methyl-4-pyrazole carboxamide (Compound No. 2)
  • To 48.1 mL of N-methylpyrrolidone in a 300-mL four-necked flask, 22.46 g (0.110 mol) of ethyl 3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylate and 9.42 g (0.100 mol) of aniline were added in a nitrogen atmosphere.
  • Subsequently, 13.61 g (0.20 mol) of sodium ethoxide was added, and the contents were stirred at an internal temperature of 81°C for 3 hours. The reaction mixture was cooled to 68°C, and then, 99.55 g of water was added, and cooling to 1.5°C was performed, whereby a crystal was deposited. The crystal was separated by means of filtration and washed with 99.62 g of water. The crystal after washing was dried. As a result, 24.26 g of 3-(difluoromethyl)-1-methyl-N-phenyl-4-pyrazole carboxamide was obtained as a white crystal. The yield was 95.5% (on a basis of aniline), and the purity was 99.9% (HPLC area percentage), and a purification operation, such as recrystallization, was not needed.
    • Melting point: 108.7°C
    • 1H-NMR (1H resonance frequency: 500 MHz, measurement solvent: CDCl3, internal standard substance: tetramethylsilane)
  • δ value (ppm): 3.92 (3H,s), 6.92 (1H,s), 7.14 (1H,t), 7.35 (2H,t), 7.59 (2H,d), 8.00 (1H,s), 8.17 (1H,s)
  • Example 3 Synthesis of 3-(difluoromethyl)-N-(3'-methylphenyl)-1-methyl-4-pyrazole carboxamide (Compound No. 3)
  • To 50.3 mL of N-methylpyrrolidone in a 300-mL four-necked flask, 23.36 g (0.114 mol) of ethyl 3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylate and 11.13 g (0.104 mol) of 3-methylaniline were added in a nitrogen atmosphere.
  • Subsequently, 14.14 g (0.208 mol) of sodium ethoxide was added, and the contents were stirred at an internal temperature of 80°C for 2 hours. The reaction mixture was cooled to 69°C, and then, 103.58 g of water was added, and cooling to 2°C was performed, whereby a crystal was deposited. The crystal was separated by means of filtration and washed with 77.97 g of water. The crystal after washing was dried. As a result, 25.57 g of 3-(difluoromethyl)-N-(3'-methylphenyl)-1-methyl-4-pyrazole carboxamide was obtained as a white crystal. The yield was 92.8% (on a basis of 3-methylaniline), and the purity was 99.7% (HPLC area percentage), and a purification operation, such as recrystallization, was not needed.
    • Melting point: 110.8°C
    • 1H-NMR (1H resonance frequency: 500 MHz, measurement solvent: CDCl3, internal standard substance: tetramethylsilane)
  • δ value (ppm): 2.36 (3H,s), 3.94 (3H,s), 6.90 (1H,t), 6.96 (1H,d), 7.24 (1H,t), 7.90 (1H,d), 7.44 (1H,s), 8.00 (1H,s), 8.08 (1H,bs)
  • Example 4 Synthesis of 3-(difluoromethyl)-1-methyl-N-(3'-fluorophenyl)-4-pyrazole carboxamide (Compound No. 4)
  • To 48.2 mL of N-methylpyrrolidone in a 300-mL four-necked flask, 22.45 g (0.110 mol) of ethyl 3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylate and 11.35 g (0.102 mol) of 3-fluoroaniline were added in a nitrogen atmosphere.
  • Subsequently, 13.70 g (0.201 mol) of sodium ethoxide was added, and the contents were stirred at an internal temperature of 80°C for 2.5 hours. The reaction mixture was cooled to 67°C, and then, 100.29 g of water was added, and cooling to 2°C was performed, whereby a crystal was deposited. The crystal was separated by means of filtration and washed with 53.56 g of water. The crystal after washing was dried. As a result, 26.16 g of 3-(difluoromethyl)-1-methyl-N-(3'-fluorophenyl)-4-pyrazole carboxamide was obtained as a white crystal. The yield was 95.1% (on a basis of 3-fluoroaniline), and the purity was 99.9% (HPLC area percentage), and a purification operation, such as recrystallization, was not needed.
    • Melting point: 120.7°C
    • 1H-NMR (1H resonance frequency: 500 MHz, measurement solvent: DMSOd6, internal standard substance: tetramethylsilane)
  • δ value (ppm): 3.96 (3H,s), 6.91 (1H,dt), 7.31 (1H,t), 7.34-7.43 (2H,m), 7.66 (1H,td), 8.48 (1H,s), 10.19 (1H,bs)
  • Example 5 Synthesis of 3-(difluoromethyl)-1-methyl-N-(2',6'-dimethylphenyl)-4-pyrazole carboxamide (Compound No. 5)
  • To 48.3 mL of N-methylpyrrolidone in a 300-mL four-necked flask, 22.47 g (0.110 mol) of ethyl 3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylate and 13.77 g (0.102 mol) of 2,6-dimethylaniline were added in a nitrogen atmosphere.
  • Subsequently, 13.66 g (0.201 mol) of sodium ethoxide was added, and the contents were stirred at an internal temperature of 80°C for 2 hours. The reaction mixture was cooled to 67°C, and then, 100.79 g of water was added, and cooling to 2°C was performed, whereby a crystal was deposited. The crystal was separated by means of filtration and washed with 59.60 g of water. The crystal after washing was dried. As a result, 18.32 g of 3-(difluoromethyl)-1-methyl-N-(2',6'-dimethylphenyl)-4-pyrazole carboxamide was obtained as a white crystal. The yield was 64.1% (on a basis of 2,6-dimethylaniline), and the purity was 99.7% (HPLC area percentage), and a purification operation, such as recrystallization, was not needed.
    • Melting point: 158.6°C
    • 1H-NMR (1H resonance frequency: 500 MHz, measurement solvent: CDCl3, internal standard substance: tetramethylsilane)
  • δ value (ppm): 2.27 (6H,s), 3.90 (3H,s), 6.90 (1H,t), 7.10-7.16 (3H,m), 7.74 (1H,bs), 7.97 (1H,s)
  • Example 6 Synthesis of 3-(difluoromethyl)-1-methyl-N-(2-biphenyl)-4-pyrazole carboxamide (Compound No. 6)
  • To 38.6 mL of N-methylpyrrolidone in a 300-mL four-necked flask, 17.97 g (0.088 mol) of ethyl 3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylate and 13.78 g (0.081 mol) of 2-biphenylamine were added in a nitrogen atmosphere.
  • Subsequently, 10.97 g (0.161 mol) of sodium ethoxide was added, and the contents were stirred at an internal temperature of 80°C for 2 hours. The reaction mixture was cooled to 69°C, and then, 78.81 g of water was added, and cooling to 2°C was performed, whereby a crystal was deposited. The crystal was separated by means of filtration and washed with 40.25 g of water. The crystal after washing was dried. As a result, 23.10 g of 3-(difluoromethyl)-1-methyl-N-(2-biphenyl)-4-pyrazole carboxamide was obtained as a white crystal. The yield was 86.7% (on a basis of 2-biphenylamine), and the purity was 96.7% (HPLC area percentage), and a purification operation, such as recrystallization, was not needed.
    • Melting point: 127.4°C
    • 1H-NMR (1H resonance frequency: 500 MHz, measurement solvent: CDCl3, internal standard substance: tetramethylsilane)
  • δ value (ppm): 3.88 (3H,s), 6.75 (1H,t), 7.20-7.29 (2H,m), 7.37-7.47 (6H,m), 7.70 (1H,s), 7.80 (1H,bs), 8.29 (1H,d)
  • Example 7 Synthesis of 3-(difluoromethyl)-1-methyl-N-(3',4'-dichloro-5-fluorobiphenyl-2-yl)-4-pyrazole carboxamide (Compound No. 7: a general name: bixafen)
  • To 38.8 mL of N-methylpyrrolidone in a 300-mL four-necked flask, 18.8 g (0.0921 mol) of ethyl 3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylate and 21.72 g (0.085 mol) of 3',4'-dichloro-5-fluorobiphenyl-2-ylamine were added in a nitrogen atmosphere.
  • The 3',4'-dichloro-5-fluorobiphenyl-2-ylamine was prepared by reference to WO 2006/024388 A .
  • Subsequently, 11.56 g (0.170 mol) of sodium ethoxide was added, and the contents were stirred at an internal temperature of 80°C for 2 hours. The reaction mixture was cooled to 69°C, and then, 78.71 g of water was added, and cooling to 2°C was performed, whereby a crystal was deposited. The crystal was separated by means of filtration and washed with 40.30 g of water. The crystal after washing was dried. As a result, 33.10 g of 3-(difluoromethyl)-1-methyl-N-(3', 4'-dichloro-5-fluorobiphenyl-2-yl)-4-pyrazole carboxamide was obtained as a white crystal. The yield was 94.0% (on a basis of 3',4'-dichloro-5-fluorobiphenyl-2-ylamine), and the purity was 98.8% (HPLC area percentage), and a purification operation, such as recrystallization, was not needed.
    • Melting point: 146.1°C
    • 1H-NMR (1H resonance frequency: 500 MHz, measurement solvent: CDCl3, internal standard substance: tetramethylsilane)
  • δ value (ppm): 3.91 (3H,s), 6.67 (1H,t), 6.972 (1H,dd), 7.10-7.14 (1H,m), 7.20 (1H,dd), 7.47-7.51 (2H,m), 7.73 (1H,bs), 7.90 (1H,s), 8.09 (1H,dd)
  • Example 8 Synthesis of 3-(difluoromethyl)-1-methyl-N-(3',4',5'-trifluorobiphenyl-2-yl)-4-pyrazole carboxamide (Compound No. 8: a general name: fluxapyroxad)
  • To 38.6 mL of N-methylpyrrolidone in a 300-mL four-necked flask, 17.97 g (0.088 mol) of ethyl 3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylate and 13.78 g (0.081 mol) of 3',4',5'-trifluorobiphenyl-2-ylamine were added in a nitrogen atmosphere.
  • The 3',4',5'-trifluorobiphenyl-2-ylamine was prepared by reference to WO 2010/094736 A .
  • Subsequently, 10.97 g (0.161 mol) of sodium ethoxide was added, and the contents were stirred at an internal temperature of 80°C for 2 hours. The reaction mixture was cooled to 69°C, and then, 78.90 g of water was added, and cooling to 2°C was performed, whereby a crystal was deposited. The crystal was separated by means of filtration and washed with 40.30 g of water. The crystal after washing was dried. As a result, 28.52 g of 3-(difluoromethyl)-1-methyl-N-(3',4',5'-trifluorobiphenyl-2-yl)-4-pyrazole carboxamide was obtained as a white crystal. The yield was 92.3% (on a basis of 3',4',5'-trifluorobiphenyl-2-ylamine), and the purity was 97.7% (HPLC area percentage), and a purification operation, such as recrystallization, was not needed.
    • Melting point: 156.2°C
    • 1H-NMR (1H resonance frequency: 500 MHz, measurement solvent: CDCl3, internal standard substance: tetramethylsilane)
  • δ value (ppm): 3.92 (3H,s), 6.64 (1H,t), 6.99-7.03 (2H,m), 7.20-7.25 (2H,m), 7.41-7.45 (1H,m), 7.81 (1H,bs), 7.96 (1H,s), 8.14 (1H,d)
  • Example 9 Synthesis of 2-syn isomer: 3-(difluoromethyl)-1-methyl-N-[(1RS,4SR,9RS)-1,2,3,4-tetrahydro-9-isopropyl-1,4-methanonaphthalen-5-yl]pyrazole-4-caboxamide and 2-anti isomer: 3-(difluoromethyl)-1-methyl-N-[(1RS,4SR,9SR)-1,2,3,4-tetrahydro-9-isopropyl-1,4-methanonaphthalen-5-yl]pyrazole-4-caboxamide (Compound No. 9 obtained as a mixture of the syn-form and the anti-form : a general name: isopyrazam)
  • To 48.1 mL of N-methylpyrrolidone in a 300-mL four-necked flask, 22.50 g (0.110 mol) of ethyl 3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylate and 20.13 g (0.100 mol) of a mixture of N-[(1RS,4SR,9RS)-1,2,3,4-tetrahydro-9-isopropyl-1,4-methanonaphthalen-5-yl]a mine and N-[(1RS,4SR,9SR)-1,2,3,4-tetrahydro-9-isopropyl-1,4-methanonaphthalen-5-yllamine were added in a nitrogen atmosphere.
  • The mixture of N-[(1RS,4SR,9RS)-1,2,3,4-tetrahydro-9-isopropyl-1,4-methanonaphthalen-5-yl]amine and N-[(1RS,4SR,9SR)-1,2,3,4-tetrahydro-9-isopropyl-1,4-methanonaphthalen-5-yl]a mine was prepared by reference to WO 2007/115765 A (PTL 4).
  • Subsequently, 13.61 g (0.200 mol) of sodium ethoxide was added, and the contents were stirred at an internal temperature of 81°C for 3 hours. The reaction mixture was cooled to 68°C, and then, 99.80 g of water was added, and cooling to 1.5°C was performed, whereby a crystal was deposited. The crystal was separated by means of filtration and washed with 100.00 g of water. The crystal after washing was dried. As a result, 33.07 g of a mixture of a 2-syn isomer: 3-(difluoromethyl)-1-methyl-N-[(1RS,4SR,9RS)-1,2,3,4-tetrahydro-9-isopropyl-1,4-methanonaphthalen-5-yl]pyrazole-4-caboxamide and a 2-anti isomer: 3- (difluoromethyl)-1-methyl-N- [(1RS, 4SR,9SR)-1, 2, 3, 4-tetrahydro-9-isopropyl-1, 4-methanonaphthalen-5-yl]pyrazole-4-caboxamide was obtained as a white crystal. The yield was 92.0% (on a basis of the mixture of N-[(1RS,4SR,9RS)-1,2,3,4-tetrahydro-9-isopropyl-1,4-methanonaphthalen-5-yl]amine and N-[(1RS,4SR,9SR)-1,2,3,4-tetrahydro-9-isopropyl-1,4-methanonaphthalen-5-yl] amine), and the purity was 99.5% (the total sum of HPLC area percentages of the syn-form and the anti-form), and a purification operation, such as recrystallization, was not needed.
    • Melting point: 130.0°C (syn-form) and 144.4°C (anti-form)
    • 1H-NMR (1H resonance frequency: 500 MHz, measurement solvent: CDCl3, internal standard substance: tetramethylsilane)
  • δ value (ppm): syn-form: 0.8 (6H,s), 1.0 (1H,m), 1.2-2.0 (5H,m), 3.2-3.4 (2H,m), 4.0 (3H,s), 6.6-8.2 (6H,m), and anti-form: 0.9 (6H,s), 1.0-2.0 (6H,m), 3.2-3.4 (2H,m), 4.0 (3H,s), 6.7-8.1 (6H,m)
  • Example 10 Synthesis of 3-(difluoromethyl)-1-methyl-N-[(1RS,4SR)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]pyrazole-4-carboxamide (Compound No. 10: a general name: benzovindiflupyr)
  • To 13.0 mL of N-methylpyrrolidone in a 300-mL four-necked flask, 6.09 g (0.030 mol) of ethyl 3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylate and 6.62 g (0.027 mol) of N-[(1RS,4SR)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yllamine were added in a nitrogen atmosphere.
  • The N-[(1RS,4SR)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]amine was prepared by reference to WO 2010/049228 A .
  • Subsequently, 3.70 g (0.054 mol) of sodium ethoxide was added at an internal temperature of 7.0°C, the temperature was raised to an internal temperature of 65°C over 2 hours, and the contents were stirred at the same temperature for 8 hours. The reaction mixture was cooled to 63°C, and then, 26.87 g of water was added, and cooling to 4.4°C was performed, whereby a crystal was deposited. The crystal was separated by means of filtration and washed with 152.60 g of water. The crystal after washing was dried. As a result, 10.31 g of 3-(difluoromethyl)-1-methyl-N-[(1RS,4SR)-9-(dichloromethylene)-1,2,3,4-tetrahyd ro-1,4-methanonaphthalen-5-yl]pyrazole-4-carboxamide was obtained as a white crystal. The yield was 95.8% (on a basis of N-[(1RS,4SR)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5 -yl]amine), and the purity was 98.4% (HPLC area percentage), and a purification operation, such as recrystallization, was not needed.
    • Melting point: 147.4°C
    • 1H-NMR (1H resonance frequency: 500 MHz, measurement solvent: CDCl3, internal standard substance: tetramethylsilane)
  • δ value (ppm): 1.38 (1H,m), 1.49 (1H,m), 2.10 (2H,m), 3.95 (3H,s, overlapped by 1H,m), 4.06 (1H,m), 6.89 (1H,t, J = 54Hz), 7.03 (1H,d), 7.17 (1H,t), 7.82 (1H,d), 8.06 (1H,s), 8.11 (1H,bs)
  • Example 11 Synthesis of (RS)-N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide (Compound No. 11: a general name: penthiopyrad)
  • To 17.9 mL of N-methylpyrrolidone in a 300-mL four-necked flask, 24.56 g (0.111 mol) of ethyl 3-(trifluoromethyl)-1-methyl-1H-pyrazole-4-carboxylate and 18.43 g (0.101 mol) of (RS)-N-[2-(1,3-dimethylbutyl)-3-thienyl]amine were added in a nitrogen atmosphere.
  • The (RS)-N-[2-(1,3-dimethylbutyl)-3-thienyl]amine was prepared by reference to EP 0737682 A (PTL 6).
  • Subsequently, 13.65 g (0.201 mol) of sodium ethoxide was added, and the contents were stirred at an internal temperature of 70°C for 7 hours. To the reaction mixture, 48.30 g of water was added at the same temperature, and after stirring for 30 minutes, the resultant was allowed to stand at 65°C, to separate the aqueous layer. The organic layer was naturally cooled to 12.0°C over 12 hours while stirring. Subsequently, 49.58 g of water was added to the organic layer, followed by stirring at 30°C for 30 minutes. As a result, a crystal was gradually deposited. After stirring at the same temperature for 4 hours, the crystal was separated by means of filtration and washed with 77.60 g of water. The crystal after washing was dried. As a result, 33.44 g of (RS)-N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide was obtained as a white crystal. The yield was 93.2% (on a basis of (RS)-N-[2-(1,3-dimethylbutyl)-3-thienyl]amine), and the purity was 99.8% (HPLC area percentage), and a purification operation, such as recrystallization, was not needed.
    • Melting point: 108.5°C
    • 1H-NMR (1H resonance frequency: 500 MHz, measurement solvent: CDCl3, internal standard substance: tetramethylsilane)
  • δ value (ppm): 0.86 (6H,d), 1.25 (3H,d), 1.4-1.7 (3H,m), 3.09 (1H,m), 3.94 (3H,s), 7.11 (1H,d), 7.39 (1H,s), 7.61 (1H,bs), 8.02 (1H,s)
  • In the light of the above, different from the present invention, the background art is in general concerned with the usual aminolysis reaction in which a by-produced alcohol or phenol is removed outside the reaction system through fractionation or the like, and the equilibrium is shifted toward the reaction production system, thereby completing the reaction, and it may be said that the treatment after the reaction is also usual one. On the other hand, the present invention is concerned with a technology in which the pyrazole-4-caroxamide derivative can be obtained in high yield and high purity by a simple method in which the reaction can be completed without removing the by-produced alcohol or phenol outside the system, and as for the treatment after the reaction, water is added after the end of the reaction, to deposit a crystal, and thus, it is noted that the present invention is concerned with an extremely simple and safe method.
  • Industrial Applicability
  • The production method of the present invention is useful as an industrial production method in which the pyrazole-4-carboxamide derivative that is useful as an agricultural fungicide can be obtained in high yield and high purity through a short process and a simple operation.

Claims (8)

  1. A method of producing a pyrazole-4-carboxamide derivative represented by the formula (1):
    Figure imgb0016
    wherein,
    R1 is a hydrogen atom, a C1-C4 alkyl group, a C1-C4 haloalkyl group, a C3-C6 cycloalkyl group, a C3-C6 halocycloalkyl group, a C1-C4 alkoxy group, a C1-C4 haloalkoxy group, a C1-C4 alkylthio group, a C1-C4 haloalkylthio group, an aralkyl group, or an aryl group,
    R2 is a hydrogen atom, a halogen atom, a C1-C4 alkyl group, a C1-C4 haloalkyl group, a C3-C6 cycloalkyl group, a C3-C6 halocycloalkyl group, a C1-C4 alkoxy group, a C1-C4 haloalkoxy group, a C1-C4 alkylthio group, a C1-C4 haloalkylthio group, an aralkyl group, or an aryl group,
    R3 is a hydrogen atom, a halogen atom, a C1-C4 alkyl group, a C1-C4 haloalkyl group, a C3-C6 cycloalkyl group, a C3-C6 halocycloalkyl group, a C1-C4 alkoxy group, a C1-C4 haloalkoxy group, a C1-C4 alkylthio group, a C1-C4 haloalkylthio group, an aralkyl group, or an aryl group, and
    Qx is selected from Q1, Q2, Q3, Q4, Q5, and Q6:
    Figure imgb0017
    Figure imgb0018
    in Q1, R4, R5, and R6 are the same as or different from each other and are each a C1-C4 alkyl group, a C1-C4 haloalkyl group, a C3-C6 cycloalkyl group, or a C3-C6 halocycloalkyl group, provided that R5 and R6 may be bonded to each other to form a C3-C6 cycloalkyl group,
    V represents CH(R7), N(R8), an oxygen atom, or a sulfur atom, and R7 and R8 are each a hydrogen atom, a C1-C4 alkyl group, a C1-C4 haloalkyl group, a C3-C6 cycloalkyl group, or a C3-C6 halocycloalkyl group,
    Y represents a halogen atom, a C1-C4 alkyl group, a C1-C4 haloalkyl group, a C1-C4 alkoxy group, a C1-C4 haloalkoxy group, an SH group, a C1-C4 alkylthio group, or a C1-C4 haloalkylthio group, and
    m is an integer of 0 to 3;
    in Q2, Y1 represents a hydrogen atom, a halogen atom, a C1-C6 alkyl group, a C1-C6 haloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, an SH group, a C1-C6 alkylthio group, or a C1-C6 haloalkylthio group, and
    n is an integer of 1 to 5, and when n is 2, 3, 4, or 5, then Y1's may be the same as or different from each other;
    in Q3, Y1 and Z each represent a hydrogen atom, a halogen atom, a C1-C6 alkyl group, a C1-C6 haloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, an SH group, a C1-C6 alkylthio group, or a C1-C6 haloalkylthio group,
    p represents an integer of 1 to 4, and when p is 2, 3, or 4, then Y1's may be the same as or different from each other, and
    n represents an integer of 1 to 5, and when n is 2, 3, 4, or 5, then Z's may be the same as or different from each other;
    in Q4, R9, R10, R11, R12, R13, and R14 are the same as or different from each other and each represent a hydrogen atom, a halogen atom, a C1-C6 alkyl group, a C1-C6 haloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, an SH group, a C1-C6 alkylthio group, or a C1-C6 haloalkylthio group, R11 and R12 may be bonded to each other to form a C3-C6 cycloalkyl group and R13 and R14 may be bonded to each other to form a C3-C6 cycloalkyl group, and
    W represents a methylene group, a methine group substituted with a C1-C6 haloalkyl group, or a terminal end-substituted vinyl group represented by the formula (4):
    Figure imgb0019
    wherein T represents a C1-C6 haloalkyl group or a halogen atom;
    in Q5, Y1 represents a hydrogen atom, a halogen atom, a C1-C6 alkyl group, a C1-C6 haloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, an SH group, a C1-C6 alkylthio group, or a C1-C6 haloalkylthio group,
    m represents an integer of 1 to 3, and when m is 2 or 3, then Y1's may be the same as or different from each other, and
    G represents an oxygen atom, a sulfur atom, or N(R15), and R15 represents a hydrogen atom or a C1-C6 alkyl group; and
    in Q6, Y1 represents a hydrogen atom, a halogen atom, a C1-C6 alkyl group, a C1-C6 haloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, an SH group, a C1-C6 alkylthio group, or a C1-C6 haloalkylthio group,
    m represents an integer of 1 to 3, and when m is 2 or 3, then Y1's may be the same as or different from each other, and
    G represents an oxygen atom, a sulfur atom, or N(R15), and R15 represents a hydrogen atom or a C1-C6 alkyl group,
    the method comprising subjecting a pyrazole-4-carboxylic acid ester represented by the formula (2):
    Figure imgb0020
    wherein,
    R1 is a hydrogen atom, a C1-C4 alkyl group, a C1-C4 haloalkyl group, a C3-C6 cycloalkyl group, a C3-C6 halocycloalkyl group, a C1-C4 alkoxy group, a C1-C4 haloalkoxy group, a C1-C4 alkylthio group, a C1-C4 haloalkylthio group, an aralkyl group, or an aryl group,
    R2 is a hydrogen atom, a halogen atom, a C1-C4 alkyl group, a C1-C4 haloalkyl group, a C3-C6 cycloalkyl group, a C3-C6 halocycloalkyl group, a C1-C4 alkoxy group, a C1-C4 haloalkoxy group, a C1-C4 alkylthio group, a C1-C4 haloalkylthio group, an aralkyl group, or an aryl group,
    R3 is a hydrogen atom, a halogen atom, a C1-C4 alkyl group, a C1-C4 haloalkyl group, a C3-C6 cycloalkyl group, a C3-C6 halocycloalkyl group, a C1-C4 alkoxy group, a C1-C4 haloalkoxy group, a C1-C4 alkylthio group, a C1-C4 haloalkylthio group, an aralkyl group, or an aryl group, and
    R is a C1-C4 alkyl group or an optionally substituted phenyl group,
    and an amine represented by the formula (3):

            H2N-Qx     (3)

    wherein
    Qx represents any substituent (amine residue) of Q1, Q2, Q3, Q4, Q5, and Q6:
    Figure imgb0021
    Figure imgb0022
    in Q1, R4, R5, and R6 are the same as or different from each other and are each a C1-C4 alkyl group, a C1-C4 haloalkyl group, a C3-C6 cycloalkyl group, or a C3-C6 halocycloalkyl group, provided that R5 and R6 may be bonded to each other to form a C3-C6 cycloalkyl group,
    V represents CH(R7), N(R8), an oxygen atom, or a sulfur atom, and R7 and R8 are each a hydrogen atom, a C1-C4 alkyl group, a C1-C4 haloalkyl group, a C3-C6 cycloalkyl group, or a C3-C6 halocycloalkyl group,
    Y represents a halogen atom, a C1-C4 alkyl group, a C1-C4 haloalkyl group, a C1-C4 alkoxy group, a C1-C4 haloalkoxy group, an SH group, a C1-C4 alkylthio group, or a C1-C4 haloalkylthio group, and
    m is an integer of 0 to 3;
    in Q2, Y1 represents a hydrogen atom, a halogen atom, a C1-C6 alkyl group, a C1-C6 haloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, an SH group, a C1-C6 alkylthio group, or a C1-C6 haloalkylthio group, and
    n is an integer of 1 to 5, and when n is 2, 3, 4, or 5, then Y's may be the same as or different from each other;
    in Q3, Y1 and Z each represent a hydrogen atom, a halogen atom, a C1-C6 alkyl group, a C1-C6 haloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, an SH group, a C1-C6 alkylthio group, or a C1-C6 haloalkylthio group,
    p represents an integer of 1 to 4, and when p is 2, 3, or 4, then Y's may be the same as or different from each other, and
    n represents an integer of 1 to 5, and when n is 2, 3, 4, or 5, then Z's may be the same as or different from each other;
    in Q4, R9, R10, R11, R12, R13, and R14 are the same as or different from each other and each represent a hydrogen atom, a halogen atom, a C1-C6 alkyl group, a C1-C6 haloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, an SH group, a C1-C6 alkylthio group, or a C1-C6 haloalkylthio group, R11 and R12 may be bonded to each other to form a C3-C6 cycloalkyl group, and R13 and R14 may be bonded to each other to form a C3-C6 cycloalkyl group, and
    W represents a methylene group, a methine group substituted with a C1-C6 haloalkyl group, or a terminal end-substituted vinyl group represented by the formula (4):
    Figure imgb0023
    wherein T represents a C1-C6 haloalkyl group or a halogen atom;
    in Q5, Y1 represents a hydrogen atom, a halogen atom, a C1-C6 alkyl group, a C1-C6 haloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, an SH group, a C1-C6 alkylthio group, or a C1-C6 haloalkylthio group,
    m represents an integer of 1 to 3, and when m is 2 or 3, then Y1's may be the same as or different from each other, and
    G represents an oxygen atom, a sulfur atom, or N(R15), and R15 represents a hydrogen atom or a C1-C6 alkyl group; and
    in Q6, Y1 represents a hydrogen atom, a halogen atom, a C1-C6 alkyl group, a C1-C6 haloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, an SH group, a C1-C6 alkylthio group, or a C1-C6 haloalkylthio group,
    m represents an integer of 1 to 3, and when m is 2 or 3, then Y1's may be the same as or different from each other, and
    G represents an oxygen atom, a sulfur atom, or N(R15), and R15 represents a hydrogen atom or a C1-C6 alkyl group,
    to an aminolysis reaction in a solvent in the presence of a base, provided that the reaction is completed without removing a by-produced alcohol or phenol,
    wherein the solvent to be used for the reaction is an aprotic solvent,
    the method further comprising:
    (i) after completion of the reaction, adding water to the reaction mixture to deposit the target material, and subjecting the resultant to filtration, followed by drying, to thereby obtain a pyrazole-4-carboxamide derivative, or
    (ii) after completion of the reaction, adding water to the reaction mixture, separating the aqueous layer to remove an unnecessary material from the organic layer containing the target material, adding water to the remaining organic layer to deposit the target material, and subjecting the resultant to filtration, followed by drying, to thereby obtain a pyrazole-4-carboxamide derivative.
  2. The production method according to claim 1, wherein the base to be used for the reaction is a metal alkoxide.
  3. The production method according to claim 2, wherein the metal alkoxide is at least one selected from lithium methoxide, lithium ethoxide, sodium methoxide, sodium ethoxide, potassium methoxide, and potassium ethoxide.
  4. The production method according to any one of claims 1 to 3, wherein, as for a charging ratio of the pyrazole carboxylic acid ester represented by the formula (2) and the amine represented by the formula (3), the amount of the pyrazole carboxylic acid ester is in a range of 1.0 to 2.0 equivalents to 1.0 equivalent of the amine.
  5. The production method according to any one of claims 1 to 4, wherein the use amount of the base is in a range of 1.0 to 7.0 equivalents to 1.0 equivalent of the amine represented by the formula (3).
  6. The production method according to any one of claims 1 to 5, wherein the solvent to be used for the reaction is selected from the group consisting of N,N-dimethylacetamide, N-methylpyrrolidone, N,N-dimethylformamide and dimethyl sulfoxide.
  7. The production method according to any one of claims 1 to 6, wherein the use amount of the solvent is in a range of 0.5 to 10.0 equivalents relative to the amine represented by the formula (3).
  8. The production method according to any one of claims 1 to 7, wherein the amount of water needed for deposition in the above (i) and (ii) is about 1.0 to 7.0 in terms of a mass ratio relative to the used solvent.
EP18850343.7A 2017-08-28 2018-07-23 Production method for pyrazole-4-carboxamide derivative Active EP3677572B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017163730 2017-08-28
PCT/JP2018/027485 WO2019044266A1 (en) 2017-08-28 2018-07-23 Production method for pyrazole-4-carboxamide derivative

Publications (4)

Publication Number Publication Date
EP3677572A1 EP3677572A1 (en) 2020-07-08
EP3677572A4 EP3677572A4 (en) 2021-03-24
EP3677572C0 EP3677572C0 (en) 2023-06-07
EP3677572B1 true EP3677572B1 (en) 2023-06-07

Family

ID=65527398

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18850343.7A Active EP3677572B1 (en) 2017-08-28 2018-07-23 Production method for pyrazole-4-carboxamide derivative

Country Status (5)

Country Link
US (1) US20200181091A1 (en)
EP (1) EP3677572B1 (en)
JP (1) JP7220151B2 (en)
CN (1) CN110891940A (en)
WO (1) WO2019044266A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113402464A (en) * 2021-03-15 2021-09-17 深圳市谦陌通辰实验有限公司 Synthetic method of fluxapyroxad based on Suzuki reaction
CN113149908A (en) * 2021-04-08 2021-07-23 深圳市雁程化工有限公司 Bixafen synthesis method based on Suzuki reaction
WO2024017788A1 (en) * 2022-07-22 2024-01-25 Syngenta Crop Protection Ag Solid form of a heterocyclic amide derivative

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0654464A1 (en) 1993-10-22 1995-05-24 Shell Internationale Researchmaatschappij B.V. Processes for the preparation of pesticides and intermediates
DE69618370T2 (en) 1995-04-11 2002-09-26 Mitsui Chemicals Inc Substituted thiophene derivatives and fungicides containing them as an active ingredient for agriculture and horticulture
DE10215292A1 (en) 2002-02-19 2003-08-28 Bayer Cropscience Ag New N-biphenylyl-1-methyl-3-(di- or trifluoromethyl)-1H-pyrazole-4-carboxamides, useful as microbicides, especially fungicides and bactericides for protection of plants or materials such as wood
JP2008502636A (en) 2004-06-18 2008-01-31 ビーエーエスエフ アクチェンゲゼルシャフト N- (Ortho-phenyl) -1-methyl-3-difluoromethylpyrazole-4-carboxyanilide and their use as fungicides
DE102004041531A1 (en) 2004-08-27 2006-03-02 Bayer Cropscience Ag Process for the preparation of biphenylamines
DE102005007160A1 (en) 2005-02-16 2006-08-24 Basf Ag Pyrazolecarboxylic acid anilides, process for their preparation and compositions containing them for controlling harmful fungi
WO2006090778A1 (en) 2005-02-25 2006-08-31 Sagami Chemical Research Center Method for producing 1-substituted-3-fluoroalkyl pyrazole-4-carboxylate
EP1904450A1 (en) 2005-07-18 2008-04-02 Syngeta Participations AG Pyrazole-4- carboxamide derivatives as microbiocides
TW200804292A (en) 2005-09-16 2008-01-16 Syngenta Participations Ag Process for the production of amides
TWI374126B (en) 2005-10-25 2012-10-11 Syngenta Participations Ag Novel microbiocides
MX2008012708A (en) 2006-04-06 2008-10-10 Syngenta Participations Ag Fungicidal compositions.
BRPI0920833B1 (en) 2008-10-27 2018-02-06 Syngenta Participations Ag BENZONORBORB PREPARATION
US8492558B2 (en) 2009-02-19 2013-07-23 Basf Se Method for producing 2-aminobiphenylene
JP6367556B2 (en) * 2010-10-27 2018-08-01 ソルヴェイ(ソシエテ アノニム) Method for producing pyrazole-4-carboxamide
BR112013032988A2 (en) 2011-06-21 2016-08-16 Bayer Ip Gmbh method for the production of pyrazolylcarboxanilides
ITMI20121045A1 (en) 2012-06-15 2013-12-16 Isagro Ricerca Srl SYNERGIC COMPOSITIONS FOR THE PROTECTION OF AGRICULTURAL CROPS AND ITS USE
AU2014381760B2 (en) * 2014-02-07 2018-08-02 Sumitomo Chemical Company, Limited Method for producing (R)-1,1,3-trimethyl-4-aminoindane
EP2980078A1 (en) * 2014-07-29 2016-02-03 Solvay SA Process for the preparation of pyrazole-4-carboxamides
US11944626B2 (en) * 2016-06-20 2024-04-02 The Regents Of The University Of Michigan Small molecule inhibitors of ALDH and uses thereof

Also Published As

Publication number Publication date
EP3677572A4 (en) 2021-03-24
US20200181091A1 (en) 2020-06-11
EP3677572C0 (en) 2023-06-07
JPWO2019044266A1 (en) 2020-08-13
CN110891940A (en) 2020-03-17
WO2019044266A1 (en) 2019-03-07
EP3677572A1 (en) 2020-07-08
JP7220151B2 (en) 2023-02-09

Similar Documents

Publication Publication Date Title
JP6254646B2 (en) Tetrazole-substituted anthranilamide derivatives and process for producing novel crystalline polymorphs of these derivatives
KR100953251B1 (en) Substituted dihydro 3-halo-1H-pyrazole-5-carboxylates their preparation and use
EP1537097B1 (en) Method for preparing 3-halo-4,5-dihydro-1 i h /i -pyrazoles
JP4725977B2 (en) Process for producing 2-dihaloacyl-3-amino-acrylic acid ester and 3-dihalomethyl-pyrazole-4-carboxylic acid ester
EP3677572B1 (en) Production method for pyrazole-4-carboxamide derivative
KR101208748B1 (en) 2--5--3- preparation and use of 2-substituted-5-oxo-3-ryrazolidinecarboxylates
US20140235862A1 (en) Method for producing 4, 4-difluoro-3,4-dihydroisoquinoline derivatives
FR2614620A1 (en) 1,4-DIHYDRO-4-OXONAPHTYRIDINE DERIVATIVES AND THEIR SALTS, PROCESS FOR THEIR PRODUCTION AND ANTI-BACTERIAL AGENTS CONTAINING SAME
CA2696237C (en) Indol-2-one derivatives disubstituted in the 3-position, preparation thereof and therapeutic use thereof
KR101730393B1 (en) New process for preparing pyrazole carboxylic acid derivatives
JP5815507B2 (en) Process for purification of 1-methylpyrazole-4-carboxylic acid ester
CA3053734A1 (en) Thiazole compounds and herbicide
EP2456747B1 (en) Method for preparing alkoxyenones and enaminoketones
EP2894150B1 (en) Method for producing 1-substituted-3-fluoroalkylpyrazole-4-carboxylic acid ester
JP2010509272A (en) Method for sulfinylation of pyrazole derivatives
JP2013006779A (en) Method for producing pyrazole compound
JP4336913B2 (en) Method for producing amide derivative
RU2702121C1 (en) Method of producing 2-amino-nicotinic acid benzyl ester derivative
EP2174940A1 (en) Process for production of optically active mirtazapine
RU2300526C2 (en) Method for preparing phenoxy-substituted 2-pyridone compounds
TW202346260A (en) Methods for the preparation of 5-chloro-2-((ethoxycarbonyl)amino)-3-methylbenzoic acid
JP2011153114A (en) Aniline derivative, and method for producing the same
KR20180101396A (en) Process for producing acid halide solution and process for producing monoester compound
KR20130132854A (en) Novel process for production of a-methyl-b-ketoester
JP2014037389A (en) Method for manufacturing ester compound and method for manufacturing azolyl methyl cyclopentanol compound

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20200107

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20210219

RIC1 Information provided on ipc code assigned before grant

Ipc: C07D 409/12 20060101ALI20210215BHEP

Ipc: C07D 231/14 20060101AFI20210215BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20221208

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

Ref country code: AT

Ref legal event code: REF

Ref document number: 1574695

Country of ref document: AT

Kind code of ref document: T

Effective date: 20230615

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602018051530

Country of ref document: DE

U01 Request for unitary effect filed

Effective date: 20230607

U07 Unitary effect registered

Designated state(s): AT BE BG DE DK EE FI FR IT LT LU LV MT NL PT SE SI

Effective date: 20230629

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

U20 Renewal fee paid [unitary effect]

Year of fee payment: 6

Effective date: 20230824

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230907

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230607

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230607

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230607

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230908

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230607

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231007

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230607

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230607

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230607

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231007

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230607

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230607

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230607

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230607